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1 Introduction 
1.1 Macrophages 
Macrophages are indispensible in the maintenance of tissue homeostasis, through the 
initiation of inflammatory responses to invading pathogens, clearance of senescent cells, 
organ modeling and wound healing [1]. Macrophages are present in large numbers lining 
lamina propia of a mucosa, pulmonary alveoli, juxtaglomerular and perivascular spaces, bony 
trabeculae, and renal tubules, where they show high a degree of heterogeneity which reflects 
the specialization of function adopted by these cells at different anatomical locations. 
Macrophage-like cells appear early during ontogenesis in the yolk sac [1]. Later in 
development, macrophages resembling those that are present in adults are generated in large 
numbers in the haematopoietic fetal liver, from where they colonize most organs [1] (Fig. 
1.1). The current classification of phagocytic cells operates in a framework of the 
mononuclear phagocyte system, which includes macrophages and their monocyte precursors 
and lineage-committed bone-marrow precursors. Although monocytes can serve for the 
replenishment of tissue-resident macrophage populations, there is solid evidence for self-
renewal of macrophages in many peripheral organs, e.g. in the skin [2] or lung [3, 4]. 
 
 
Fig. 1.1 Development of the mononuclear phagocyte system. 
Adapted by permission from Macmillan Publishers Ltd: Nature Reviews: Immunology, 
Gordon S. and Taylor P.R. [1]. M-CSF = macrophage colony stimulating factor, HSC = 
hematopoietic stem cell, GM-CFU = granulocyte/macrophage colony forming unit, M-CFU = 
macrophage colony forming unit, G-CFU = granulocyte colony forming unit 
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1.2 Origin of alveolar macrophages 
In the lung, macrophages are present in two distinct compartments: lung interstitium and 
alveolar region. It has been suggested that lung interstitial macrophages (IM) are intermediate 
between blood monocytes and alveolar macrophages (AM) [4]. Inflammatory monocytes, 
which carry CCR2 receptors and Ly6C molecules on their surface, are recruited and 
differentiate into macrophages at the site of inflammatory lesions. This was confirmed by 
experiments in which CCL2, the ligand of CCR2 receptors, was deposited into the lung [5]. 
CCL2 is the major chemokine that drives monocyte recruitment in bacterial [6] and viral [7] 
models of lung inflammation. The hypothesis of self-renewal of AM has been addressed in 
animal models and human subjects undergoing bone marrow transplantation. If lungs of 
irradiated mice, which subsequently received bone marrow transplantation, were protected 
from radiation, animals retained most of the recipient AM 1 year after the treatment [1]. 
However, after whole-body irradiation and transfer of GFP-labeled bone marrow, host AM 
were replaced with cells of donor origin, indicating that AM can be replenished from the bone 
marrow [1]. This was further refined in experiments in which the resident lung mononuclear 
phagocytes were depleted by diphtheria toxin. After bone marrow transplantation, phagocytic 
cells that recolonized the lung tissue were identified as blood derived monocytes, which then 
moved into the interstitium, acquired macrophage-like phenotype and finally reached alveoli 
[4]. Moreover, it has been shown by staining with antibodies detecting PCNA (proliferating 
cell nuclear antigen) that IM and AM proliferate follow depletion [4]. Studies on humans who 
have received allogeneic bone-marrow transplants support this notion and indicate that this 
replenishment occurs by recruitment of precursors, followed by proliferation of macrophages 
in situ [3, 8]. It is postulated that replenishment of AM in non-inflammatory conditions is 
dependent on monocytes which lack the expression of CCR2 and Ly6C molecules, but 
upregulate CX3CR1 receptors [1]. 
 
1.3 Function of alveolar macrophages 
Lung macrophages represent the first line of defence to inhaled environmental toxins and 
pathogens. In the stady state condition, the leukocyte population in the alveolar space is 
dominated by AM (90%), the reminder being mainly dendritic cells and T cells [9].  The 
major function of AM is phagocytosis and sequestration of antigen from the immune system 
to shield the alveolus from the development of specific immune response [9], thus ensuring 
proper gas exchange. High levels of expression of surface receptors, including pattern 
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recognition receptors such as scavenger receptors, mannose receptors, and the β-glucan 
specific receptor [10], allow AM to vigorously phagocytose material which was deposited 
into the lung. It is unclear if AM transport antigens to regional lymph nodes and have a 
significant role in antigen presentation. Previous data suggested that lung antigens are 
exclusively transported in a CCR7-dependent fashion by dendritic cells [11], but recent work 
by Kirby et al. showed that murine AM constitutively migrate from the lung to draining 
lymph nodes, and following exposure to Streptococcus pneumoniae, AM rapidly transport 
bacteria to this site [12]. The potential role of these migrating AM in antigen presentation 
remains elusive. Interestingly, AM actively suppress the induction of adaptive immunity in 
the lung. Studies with clodronate-filled liposomes which selectively deplete AM when given 
intratracheally, showed that treated rodents were susceptible to T cell-mediated inflammatory 
responses to otherwise harmless antigens [9]. This phenomenon was attributed to the 
enhanced antigen presentation by dendritic cells, indicating that AM might be inhibitory upon 
antigen presenting cells. 
In the steady state condition, AM are maintained in a quiescent state and produce small 
amounts of pro-inflammatory cytokines. Equipped with surface receptors for numerous 
ligands, AM can respond to environmental factors, including cytokines, microorganisms and 
particulate material with the secretion of a large number of products [9]. Activation of AM 
results in a shift in their functional capacity to phagocytosis [13], microbial killing [14], and 
initiating immune response by secreting cytokines like TNFα and IL-1β which are essential 
for activation of the epithelium and downstream inflammatory responses [15]. Moreover, AM 
produce chemokines such as CCL2 and CCL5, which recruit activated monocytes and 
lymphocytes into sites of inflammation in the lungs [16]. 
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Fig. 1.2 Initiation of inflammatory response by alveolar macrophages. 
Alveolar macrophages recognizing microbes activate epithelial cells by secreting TNFα and 
IL-1β. These diverse activation pathways converge on nuclear factor (NF-κB), which drives 
transcription of proinflammatory mediators, including neutrophil chemokines, colony-
stimulating factors, and adhesion molecules. Additionally, AM produce chemokines (CCL2, 
CCL5) which recruit activated monocytes and lymphocytes into sites of inflammation in the 
lungs. AM = alveolar macrophages, AEC = alveolar epithelial cells, IL-1β = interleukin 1β 
TNFα = tumor necrosis factor α.  
 
1.4 Paracrine and autocrine signaling in macrophages 
As it has been indicated in the previous section, AM actively sense and signal to their 
environment. This communication is rarely achieved by direct cell contact; more often cells 
secrete and respond to soluble mediators, i.e. chemokines and cytokines. Signaling by 
extracellular, secreted molecules can be classified into three types — endocrine, paracrine, or 
autocrine, based on the distance between the source of signal and the receiver. Cells are 
equipped with vast array of receptors linked with intracellular signaling pathways that allow 
them to receive and process signals. Cell surface receptors on macrophages important for this 
signaling include ligand-gated ion channels and G-protein-coupled receptors (GPCR). 
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1.4.1 Ligand-gated ion channels 
The nicotinic acetylcholine receptors (nAChR) are prototypic ligand-gated ion channels, 
which all share similar architecture and function [17]. Parts of the transmembrane domains of 
the receptor subunits create a hydrated pore that is also permeable to selected ions (Fig. 1.3). 
Since ion-channel receptors reside in a constant equilibrium between open and closed states, 
receptors contain components that are responsive to and regulated by the presence of external 
compounds such as activators (agonists), inhibitors (antagonists), or compounds that modify 
the efficacy of these agents [17]. Conformation of the receptor changes upon agonist binding 
from hydrophobic-based, channel closed configuration to a more open, hydrophilic channel 
that favors the ion passage [17]. Role and function of nAChR in immune cells will be 
discussed in further details in the section 1.6. 
 
Intracellular  
Fig. 1.3 Structure of the nAChR. 
Adapted and modified from Cloëz-Tayarani I. and Changeux J.P. 2007 [18] (A) Three-
dimensional, computerized model of the pentameric α7 nAChR (B) Schematic drawing 
illustrating positions of ligand binding pockets (triangles) at the interfaces between the 
helices.  
 
1.4.2 G-protein-coupled receptors 
GPCR, also known as seven-transmembrane domain receptors, constitute the largest known 
superfamily of cell-surface receptors with ~1000 distinct receptors encoded in the human 
genome [19]. Despite their diversity, all GPCR mediate their effects, at least in part, through 
coupling to heterotrimeric G proteins [19], comprising α, β, and γ subunits. The α subunit is 
responsible for GTP and GDP binding and for GTP hydrolysis, whereas the β and γ subunits 
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are associated in a tightly linked βγ complex [20]. Activation of a GPCR triggers 
conformational change that leads to G protein activation by exchange of bound GDP to GTP 
(Fig. 1.4). The activated heterotrimer dissociates into an α subunit and a βγ dimer, both of 
which have an independent capacity to regulate separate effectors (Tab. 1.1) [20]. Upon 
agonist activation of receptors, a rapid attenuation of receptor responsiveness occurs through 
feedback mechanisms, which involve phosphorylation of activated GPCR by GPCR kinases 
and/or second messenger-dependent kinases [19].  
 
 
Tab. 1.1 Examples of heterotrimeric G-protein mediated effector functions. 
Based on Pierce K.L, Premont R.T. and Lefkowitz R.J. [20]. ↑ denotes activation, ↓ denotes 
inhibition, cAMP = cyclic adenosine monophosphate, Ins(1,4,5)P3 = inositol-1,4,5-
trisphosphate, DAG = diacylglycerol, GEF = guanine nucleotide exchange factor 
 
G-protein subunit Function 
Gαs ↑Adenylyl cyclase, increase in cAMP levels 
Gαi ↓Adenylyl cyclase, decrease in cAMP levels 
Gαq, Gα11 ↑Phospholipase C, increase in Ins(1,4,5)P3 and DAG levels 
Gα12, Gα13 ↑Rho-GEF, ↑Rho, induction of stress-fiber formation 
Gβγ ↑Adenylyl cyclase, ↑Phospholipase C, increase in cAMP and 
Ins(1,4,5)P3 levels 
Introduction 
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Fig. 1.4 GPCR signaling. 
Adapted and modified from Lattin et al. [19]. Ligand binding induces conformational changes 
in the receptor, which binds G-proteins and promotes its activation. The GTP-bound α-subunit 
dissociates from the βγ-subunits; the free subunits regulate effector proteins which translate 
receptor stimulation to the biological effects. Signaling through GPCR is terminated by 
receptor desensitization and internalization.  
 
1.5 Role of Ca2+ in regulation of macrophage function 
1.5.1 Calcium homeostasis in immune cells 
Ca2+ is a highly versatile intracellular signal that can regulate many different cellular 
functions over a wide dynamic range [21]. The level of intracellular Ca2+ concentration 
([Ca2+]i) is determined by a balance between the ‘on’ reactions that introduce Ca2+ into the 
cytosol and the ‘off ’ reactions through which this signal is removed by the combined action 
of buffers, pumps and exchangers [21]. Duration, amplitude and spatio-temporal patterning of 
[Ca2+]i signal control various cellular activities, from exocytosis, which starts within 
microseconds after Ca2+ rise, to gene transcription that requires several minutes to hours of 
prolonged [Ca2+]i elevation [22] (Fig. 1.5).  
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Fig. 1.5 Calcium-signaling dynamics and homeostasis. 
Adapted by permission from Macmillan Publishers Ltd: Nature Reviews: Molecular Cell 
Biology, Berridge M.J., Bootman M.D and Roderick H.L [22]. Different stimuli induce entry 
of external Ca2+ and the formation of second messengers that liberate Ca2+ from intracellular 
Ca2+ stores. Most of this Ca2+ (red circles) is bound to buffers, whereas a small proportion 
binds to the effectors that activate a variety of cellular processes in spatio-temporal fashion. 
During the “off' reactions” Ca2+ is removed from cytosol by various exchangers and pumps. 
NCX = Na+/Ca2+ exchanger, PMCA = plasma-membrane Ca2+-ATPase, SERCA = 
sarco(endo)plasmic reticulum Ca2+-ATPase, ER/SR = endoplasmic/sarcoplasmic reticulum, 
[Ca2+] = Ca2+ concentration, Ins(1,4,5)P3R = inositol-1,4,5-trisphosphate receptor, RYR = 
ryanodine receptor. 
 
Both external and internal sources of Ca2+ are utilized by immune cells to initiate their Ca2+ 
signals (Fig. 1.6). In macrophages, extracellular Ca2+ influx can be triggered by agonist 
binding to ligand-gated ion channels, e.g. purinergic P2X receptors [23]. However, the 
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predominant pathway of increase in [Ca2+]i is thought to involve formation of second 
messengers and release of Ca2+ from the intracellular stores within the membrane systems of 
the endoplasmic reticulum (ER) [22, 24]. Various channels like the inositol-1,4,5-
trisphosphate receptor and ryanodine receptor release Ca2+ from these internal stores [25, 26]. 
In immune cells, the seven transmembrane receptors which couple to Gq/G11-proteins, and 
immunoreceptors containing immunoreceptor tyrosine-based activation motif (ITAM) are two 
important classes of proteins which activation leads to release of Ca2+ from intracellular stores 
(Fig. 1.6) [22]. 
 
 
Fig. 1.6 Calcium-mobilizing messengers. 
Adapted by permission from Macmillan Publishers Ltd: Nature Reviews: Molecular Cell 
Biology, Berridge M.J., Bootman M.D and Roderick H.L [22]. The release of Ca2+ from 
internal stores is mediated by inositol-1,4,5-trisphosphate receptor (Ins(1,4,5)P3R) or the 
ryanodine receptor (RYR). The Ins(1,4,5)P3R is regulated by inositol-1,4,5-trisphosphate 
(Ins(1,4,5)P3), which is generated by various signaling pathways using different isoforms of 
phospholipase C (PLC; β, δ, ε, and γ). Sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 
pump increases the luminal level of Ca2+, which results in sensitization of the RYR. 
PtdIns(4,5)P2 = phosphatidylinositol-4,5-bisphosphate. 
 
Release of Ca2+ from intracellular stores can increase [Ca2+]i only to a limited level, which 
depends on the amount of Ca2+ stored within the ER [24]. In immune cells, the decrease of ER 
[Ca2+] triggers activation of the pathway, resulting in opening of store-operated calcium 
channels in the plasma membrane. It has been shown that store depletion is associated with 
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the oligomerization of the ER transmembrane protein STIM1, which then moves to the ER–
plasma membrane junctions within 10–25 nm of the plasma membrane [27]. It is currently 
proposed that STIM1 directly or indirectly activates the membrane protein ORAI1, which is a 
subunit of a store-operated channel [28]. The functional relevance of this pathway has been 
recently shown in macrophages [29]. 
 
1.5.2 Macrophage immune functions dependent on calcium 
In macrophages, changes in [Ca2+]i have been associated with multiple functions, including, 
but not limited to activation, phagocytosis, microbial killing, inflammatory gene expression, 
and secretion. 
Immune recognition by macrophages depends on the ability to sense non-self or altered-self 
which leads to cell activation and increased motility. Several mechanisms and positive-
feedback loops establish and amplify phosphatidylinositol-3,4,5-trisphosphate signals that 
promote the generation of the leading edge, thus enable directional cell movement [30]. The 
requirement for Ca2+ signals in macrophage motility was recently refined by Evans and Falke 
[31]. Using fluorescent proteins to determine the cellular localizations of phosphoinositide 3-
kinase (PI3K) activity, actin, and protein kinase C, the study reports that an extracellular Ca2+ 
influx participates in a positive-feedback cycle between PI3K and F-actin at the leading edge 
[31]. Moreover, Ca2+ localizes protein kinase C to the ruffling leading edge and supports 
prolonged stimulation of PI3K by chemoattractants [31]. 
The phagocytosis is initiated by the recognition of the particle by receptors on the 
macrophage surface followed by F-actin mobilization around nascent phagosomes. As the 
phagosome maturates, the actin rim is removed [32]. While cytoskeleton dynamics have been 
shown to be regulated by Ca2+ [33], the role of this ion in phagocytosis by macrophages was 
questionable. Experiments done on macrophage cell lines and elicited peritoneal macrophages 
(PM) using different strategies of Ca2+ chelation showed varying results for the requirement 
of Ca2+ for phagocytosis of opsonized and non-opsonized targets [34-38]. Experimental 
approaches of depleting Ca2+ may not be optimal for studying the necessity of Ca2+ in the 
regulation of phagocytosis. Recent studies using genetically modified mice deficient for 
STIM1 show impaired phagocytosis in PM, which clearly indicates the requirement of Ca2+ in 
regulation of this process [29]. 
Part of the killing mechanism employed by phagocytes on phagocytosed microbes depends on 
the generation of the superoxide anion in a metabolic process known as the respiratory burst 
Introduction 
____________________________________________________________________________ 
11
[14, 39]. This process depends on the assembly and activation of a multisubunit complex 
known as the NADPH oxidase, which has been shown to be Ca2+-dependent [39, 40].  
Immune recognition induces changes in gene expression that are essential for the coordination 
of the immune response. The transcription factor nuclear factor κB (NF- κB) is an important 
integrator of inflammatory response. It has been shown that in PM treated with LPS, protein-
tyrosine kinases mediate PLCγ phosphorylation, which is followed by a [Ca2+]i increase [41]. 
Several Ca2+-dependent protein kinases are activated, and PKCβ regulates phosphorylation of 
MEKK1 protein, which then activates inhibitory κB kinase. Sequentially, NF-κB is activated, 
and transcription of inflammatory effector genes (inducible nitric-oxide synthase and TNFα) 
is promoted [41].  
Secretions of AM are crucial for initiation of inflammatory response in the alveolus. 
Macrophages activated by LPS release TNFα by exocytosis which is accompanied by 
dynamic changes in proteins regulating this process [42]. A study by Di et al. [43] suggests 
that exocytosis in macrophages is triggered by an interplay between [Ca2+]i and activated G-
proteins. In this model, increase in [Ca2+]i promotes docking of secretory vesicles to the 
plasma membrane, which allows G-protein-dependent vesicle fusion [43]. The role of [Ca2+]i 
in the release of CCL2 was also studied in the rat AM NR8383 cell line. Release of this 
chemokine was increased after stimulation with UTP nucleotide which is known to bind to 
P2Y2 receptors and activate Ca2+ transients [44]. Moreover, chelation of intracellular Ca2+ by 
BAPTA, or pharmacological inhibition of PLC abolished UTP-induced facilitation of CCL2 
release [45]. 
 
1.6 The nACh receptors in macrophages 
1.6.1 Acetylcholine synthesis, transport and degradation 
Acetylcholine (ACh), a classical transmitter of parasympathetic nerve fibres in the airways, is 
also synthesized by a large number of non-neuronal cells [46]. Phylogenetically, ACh is much 
older than nervous system, as cholinergic systems are present in bacteria and primitive plants 
[47]. Synthesis of ACh is catalyzed by choline acetyltransferase (ChAT) or carnitine 
acetyltransferase (CarAT) from the substrates choline and acetyl-CoA [46]. Both substances 
are present in all cells of the body, since choline is important for synthesis of plasma 
membrane lipids and acetyl-CoA is an intermediate between glycolysis and Krebs cycle. In 
some cells, ACh is packed into vesicles by the vesicular acetylcholine transporter (VAChT) 
and released by exocytosis. However, the majority of non-neuronal cholinergic cells are not 
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equipped with VAChT. It has been shown, that more widely expressed polyspecific organic 
cation transporters mediate release of ACh [48, 49]. Once released, ACh can activate 
acetylcholine receptors or will be cleaved by esterases e.g. acetylcholine esterase, which is 
present in neuronal synapses and on the surface of red blood cells [50]. Less efficient 
enzymes like burtyrylcholine esterase, are present in many tissues where they also contribute 
to the clearance of ACh [50]. 
1.6.2 Nicotinic acetylcholine receptors 
Receptors for acetylcholine are grouped in two large families: metabotropic muscarinic 
acetylcholine receptors and ionotropic nicotinic acetylcholine receptors (nAChR). This thesis 
will focus on the properties and functions of nAChR. As it has been outlined in section 1.4.1, 
nAChR are composed from 5 subunits. There are 9 different known ligand-binding α-
subunits (αl-α7 and α9-α10; the α8-subunit has only been found in chicken) that assemble 
to homo- or heteropentamers, partially with additional participation of two copies of a β-
subunit. Four different isoforms of β-subunits have been described [51]. Receptors with 
different subunit composition are distinct from each other with respect to ligand affinity - 
e.g. choline is more effective at α7-homopentamers than ACh - and to preference for 
mono- or divalent cations [51, 52]. Interestingly, nAChR in immune cells seem to have 
distinct properties from their neuronal counterparts. Binding of agonists or competitive 
antagonists affects the activity of adjacent (purinergic or antigen-specific) receptors and 
influences the [Ca2+]i fluxes evoked by their stimulation [53-55]. Membrane bound nAChR 
subunits have been demonstrated to interact with and to modulate signaling by β-arrestin [56], 
phosphatidyl-inositol-3-kinase [57], CD3ζ [54], and purinergic P2X-receptors [58, 59]. 
 
1.6.3 Expression and function of nAChR in macrophages 
Studies on the expression of nicotinic receptors have been hampered by the fact that 
antibodies to nAChR are prone to unspecific binding [60]. Because of the difficulties in the 
interpretation of the immunolabeling data in this context, I will provide an overview of the 
expression of mRNA coding for nAChR subunits in macrophages.  
Studies done on the murine AM cell line MH-S showed the expression of nAChR subunits α4 
and β2, but the authors did not detect the α7 subunit [61]. Similar observations were made for 
AM isolated from FVB mice which express α3-α6, α9, α10 and β2-β4 nAChR subunits [62]. 
Macrophages isolated from the lamina propia of the gut, PM as well as the Mf4/4 spleen 
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macrophage cell line showed expression of α4 and β2 nAChR subunits, whereas the α7 
nAChR subunit was not present in these cells [63]. In contrast, Wang et al. demonstrated the 
expression of α7 nAChR subunit mRNA in human monocyte-derived macrophages [64]. This 
might reflect a species difference since a low level of basal expression of α7 nAChR subunit 
mRNA in AM isolated from healthy volunteers and an increase in AM isolated from smokers 
has been reported [65]. 
The functional role of nAChR in macrophages has been mostly studied in the context of the 
cholinergic anti-inflammatory pathway, which will be described in detail in the next section. 
Here, I will review aspects of macrophage biology which have been shown to be modulated 
by nAChR.  
A recent study by van der Zanden et al. [63] examined the role of nAChR in the regulation of 
phagocytosis in PM. The phagocytosis of Enterococcus faecium, zymosan particles, 
opsonised red blood cells and acetylated low-density lipoprotein was increased in PM 
stimulated with nicotine. This nicotinic effect was inhibited by non-specific or α4β2 nAChR 
antagonist, but not by inhibitors selective for α7, α9/α10 nAChR [63]. The effects of nicotine 
on the capacity of macrophages for intracellular microbial killing were assessed in the MH-S 
cell line after infection with Legionella pneumophilia [61]. Nicotine treatment enhanced the 
replication of bacteria in the macrophages and selectively down-regulated the production of 
IL-6, IL-12 and TNFα, but not of IL-10, induced by infection [61]. Again, effects of nicotine 
were blocked by a nonselective nAChR antagonist, d-tubocurarine, but not by the α7, α9/α10 
nAChR antagonist α-bungarotoxin [61]. 
1.6.4  “Cholinergic anti-inflammatory pathway” 
The concept of the “Cholinergic anti-inflammatory pathway” arose from the observation that 
electrical stimulation of the peripheral vagus nerve decreased TNFα production during 
endotoxaemia in rats [66]. In endotoxaemic animals vagotomy increased serum and liver 
TNFα levels; this was inhibited when the transected vagus nerve was electrically stimulated. 
It was further shown that ACh and nicotine attenuated the release of pro-inflammatory 
cytokines from human monocyte-derived macrophages stimulated with LPS [66]. A 
pharmacological approach identified the α7 nAChR as an essential regulator of these anti-
inflammatory effects in monocyte-derived macrophages [64]. This notion was supported by 
analysis of α7 nAChR-deficient mice in which the protective effect of vagus nerve stimulation 
in LPS-induced endotoxaemia was lost [64]. The anti-inflammatory effects of nicotine were 
shown to be dependent on the activation of the transcription factor STAT3. A study by de 
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Jonge et al. [67] suggested that in mouse PM STAT3 was phosphorylated by the tyrosine 
kinase JAK2, which was recruited to the α7 nAChR. Surprisingly, a recent publication from 
this group shows that mouse PM do not express α7 nAChR mRNA [63]. However, α-
bungarotoxin and methyllycaconitine (antagonists at nAChR containing homo- and 
heteromeric α-subunits, including α7 and α9 subunits) or dihydro-β-erythroidine (antagonists 
at nAChR composed of α4β2 subunits) abrogated protective effects of nicotine on TNFα 
production in zymosan-induced PM [63]. No evidence for the expression of α7 nAChR in 
monocytes/macrophages has also been obtained in earlier studies by other groups [55, 61, 62]. 
While the general role of α7 nAChR as a modulator of inflammation it well established by 
experiments in α7 subunit-deficient mice [64, 68, 69], the actual localization of the 
cholinergic synapse which mediates the protective effects is elusive. Of note, the laboratory of 
Kevin Tracy [64] was not the first to identify the interaction between nicotine acting through 
α7 nAChR and TNFα. Numerous tissue culture studies have identified interactions between 
these pathways that impact neuroprotection to neurons challenged with excitotoxins [70-72].  
 
1.7 The role of 5-HT in macrophage biology 
1.7.1 Synthesis and regulated release of 5-HT 
Serotonin (5-hydroxytryptamine, 5-HT) is well known for its role in vasoconstriction as well 
as in diverse biological processes such as tissue regeneration [73], platelet activation [74], and 
immune system regulation [75]. Outside the central nervous system, most of the bodies’ 5-HT 
is produced by enterochromaffin cells. The synthesis of 5-HT from trytophan requires two 
enzymatic reactions. The first, rate limiting step is catalyzed by tryptophan hydroxylase 
(TPH) [76]. 5-Hydroxy-L-tryptophan is then converted to 5-HT by the action of the 
widespread aromatic L-amino acid decarboxylase. Two isoforms of TPH have been 
described: TPH1 is expressed in some peripheral tissues, including duodenum, while TPH2 
expression is limited to the brain [76]. Serotonin produced in the gut is released upon 
stimulation into the circulation, where it is taken up by and stored in platelets which express 
the serotonin reuptake transporter (SERT). Platelets release 5-HT upon activation in response 
to vascular wall injury, LPS [77] or allergen challenge [78]. Together with 5-HT released 
from mast cells [79], this results in increased 5-HT levels in inflammation [75]. In addition, 
activated T-cells [80] and macrophages [81] express TPH1, and dendritic cells [80], 
monocytes [82] and macrophages [83] express SERT which translocates 5-HT across the 
plasma membrane.  
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1.7.2 5-HT receptors 
Serotonin receptors build up a large family including ionotropic cation channels (5-HT3) and 
six types of metabotropic G-protein coupled receptors (Tab. 1.2) [84]. 
 
Receptor type Signal transduction pathway Mechanism of action 
5-HT1A, B, D, E, F Gαi/GαO protein coupled ↓ cAMP 
5-HT2A, B, C Gαq/Gα11-protein coupled ↑ Ins(1,4,5)P3 and DAG 
5-HT3A, B Ligand-gated Na+ and K+ ion channel Depolarization of plasma 
membrane 
5-HT4 Gαs-protein coupled ↑ cAMP 
5-HT5A Gαi/Gαo-protein coupled ↓ cAMP 
5-HT6 Gαs-protein coupled ↑ cAMP 
5-HT7 Gαs-protein coupled ↑ cAMP 
 
Tab. 1.2 Classification of 5-HT receptors 
Receptors are classified by operational, structural and transductional criteria. ↑ denotes 
increase, ↓ decrease in cellular levels of second messenger. cAMP = cyclic adenosine 
monophosphate, Ins(1,4,5)P3 = inositol-1,4,5-trisphosphate, DAG = diacylglycerol 
 
Peripheral blood mononuclear leukocytes, B-cells, T-cells, and dendritic cells express various 
subtypes of metabotropic 5-HT receptors, which have been shown to modulate cell activation, 
proliferation and cytokine and chemokine production [75, 80, 85-87]. Less is known about the 
expression and function of 5-HT receptors on macrophages. Early experiments with bone-
marrow derived murine macrophages identified 5-HT as the modulator of induced MHC class 
I and II expression. However, effects were inconsistent in different studies [75]. Conversely, 
innate immunity functions (IFNγ-induced phagocytosis, superoxide production) are generally 
enhanced by 5-HT [88, 89]. More recently, 5-HT and 5-HT1A receptor-specific agonists were 
shown to increase phagocytosis of zymosan particles by PM [90].  
A serotonergic modulation of cytokine secretion by NR8383 cells and human AM has been 
reported. Low doses of 5-HT (10-10–10-9 M) decreased TNFα and stimulated IL-10 production 
in both control and LPS-treated NR8383 cells [91]. It has been suggested that 5-HT2 receptors 
are involved in the modulation of cytokine secretion, because the 5-HT2 selective agonist DOI 
reproduced the effect of 5-HT [91]. However, use of the 5-HT2 receptor antagonist ritanserin, 
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did not abrogate the inhibitory effect of 5-HT on AM TNFα release, suggesting the 
participation of other 5-HT receptors [91]. 
 
1.8 Aim of the study 
Alveolar macrophages, the major immune cells in the lung, express a multitude of receptors 
which allow them to sense their environment and orchestrate immune response by secreting 
cytokines and chemokines. Their activity is controlled in a paracrine fashion by soluble 
mediators released from surrounding cells. Activation of AM involves generation of Ca2+ 
signals which direct cells to perform specific immune functions.  
 
The present study was aimed to determine to which extend, and via which receptor, 5-HT, an 
amine released from activated platelets, and nAChR, a receptor class that has been identified 
in mediating anti-inflammatory effects, also participate in paracrine modulation of AM 
function. To this end the expression of nAChR and 5-HT receptors in AM was examined and 
functional changes in [Ca2+]i in response to paracrine signals were monitored. The role of 5-
HT in modulation of AM was further explored by studying chemokine and cytokine 
secretions. 
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2 Materials and methods 
2.1 Materials 
2.1.1  Animals 
Female Wistar rats were obtained from the local animal breeding facility (Institute of 
Physiology, Justus-Liebig-University, Giessen, Germany).  
Male and female wild-type C57BL6N mice were purchased from Charles River (Sulzfeld, 
Germany). Wild-type Swiss Webster mice were purchased from Charles River (Portage, 
USA). All animals were kept in specific-pathogen free facility with free access to food and 
water. Mice were used throughout the study between 8 and 12 weeks of age.  
The animals deficient for 5-HT2C receptor were generated by Dr. Laurence H. Tecott 
(Department of Psychiatry, University of California, San Francisco, USA) [92] and obtained 
from Dr. Pete Clifton (Department of Psychology, University of Sussex, Falmer, Brighton, 
UK). Mice were bred using heterozygotes as breeders by Mfd Diagnostics (Wendelsheim, 
Germany). Offspring was genotyped using primer pairs for  the 5-HT2C gene and the 
neomycin resistance cassette. Mice were used throughout the study between 8 and 12 weeks 
of age. All animals were kept with free access to food and water under conventional housing 
conditions. Experimental protocols involving animals were approved by institutional and local 
government comities, following the current version of the Law on the Protection of Animals 
as well as the NIH “principles of laboratory animal care”. 
2.1.2 Equipment 
Calcium imaging system TILL Photonics, Germany 
Cell culture incubator Heraeus, Germany 
Confocal Laser Scanning Microscope, TCS SP2 Leica, Germany 
Cryostat, HM560 Microstar Microm, Germany 
Electrophoresis apparatus  PeqLab, Germany 
Eppendorf tubes (1.5 ml/2 ml)  Eppendorf, Germany 
Filter tip Greiner bio-one, Germany 
Filter units Millipore, USA 
Fluorescence 8 chamber glass slides BD, Germany 
Fluorescence microscope, Axioplan 2 Zeiss, Germany 
Flow cytometer, FACSCalibur BD, USA 
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Gel documentation system Phase, Germany 
MasterCycler Personal Eppendorf, Germany 
MasterCycler Gradient Eppendorf, Germany 
Microscope, BX50W Olympus, Germany 
Mini spin centrifuge, Biofuge Fresco Heraeus, Germany 
Mini Trans Blot Hoefer, USA 
Mixer Mill, MM 301 Retsch, Germany 
Multifuge centrifuge Heraeus, Germany 
PCR tubes (0.2 ml) Applied Biosystems, USA 
Pipetmans: P10, P20, P100, P200, P1000 Gilson, France 
Pipette tip BD, Germany 
Power supply Hoefer, USA 
Safety Cabinet, HERAsafe Heraeus, Germany 
Serological pipette: 5, 10, 25, 50 ml BD Falcon, Germany 
Spectrophotometer, Biophotometer Eppendorf, Germany 
Test tubes: 15, 50 ml Greiner bio-one, Germany 
Test tube thermostat  Kleinfeld, Germany 
Tissue culture plates: 24 well Greiner bio-one, Germany 
2.1.3 Kits 
DNeasy extraction kit Qiagen, Germany 
iScript Bio-Rad, Germany 
Mouse Cytokine Antibody Array, Panel A (ARY006) R&D Systems, Germany 
RNeasy Mini kit  Qiagen, Germany 
SuperScript II  Invitrogen, Germany 
SuperSignal West Pico ECL detection kit Thermo, USA 
 
2.1.4 Reagents 
Acetic Acid Merck, Germany 
4',6-diamidino-2-phenylindole (DAPI) Sigma-Aldrich, Germany 
1-chloro-2,2,2-trifluoroethly difluoromethyl ether 
 (Isoflurane) 
Abbott, Germany 
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Acetone Merck, Germany 
Acrylamide solution, Rotiphorese Gel 30 Roth, Germany 
Agarose Peqlab, Germany 
Ammonium persulfate (APS) Promega, Germany 
AmpliTaq DNA polymerase Applied Biosystems, USA 
Bovine serum albumin (BSA) Sigma-Aldrich, Germany 
Bromophenol blue Sigma-Aldrich, Germany 
Calcium chloride (CaCl2•2H20) Merck, Germany 
D-glucose Sigma-Aldrich, Germany 
Dithiothreitol (DTT) Invitrogen, Germany 
DMEM/F12 GlutaMax-I medium Invitrogen, Germany 
DNA low range marker (100 bp) Fermentas, USA 
dNTPs Applied Biosystems, USA 
Dublecco’s phosphate buffered saline (PBS) PAA Laboratories, Austria 
Ethanol Carl Roth, Germany 
Ethidium bromide solution Carl Roth, Germany 
Ethylendinitrilo-N, N, N´, N´, -tetra-acetic acid 
 disodium salt (EDTA)  
Fluka, Germany 
Ethylene glycol-bis (2-amino-ethylether)- 
N,N,N’,N’–tetra-acetic-acid (EGTA) 
Sigma-Aldrich, Germany 
Glycerol Merck, Germany 
Glycine Sigma-Aldrich, Germany 
Hepes Sigma-Aldrich, Germany 
Hydrochloric acid (HCl) Merck, Germany 
Isopropanol Merck, Germany 
Magnesium chloride (MgCl2, 15 mM) solution  Applied Biosystems, USA 
Magnesium chloride (MgCl2•6H2O) Merck, Germany 
β-mercaptoethanol Sigma-Aldrich, Germany 
Methanol Fluka, Germany 
N,N,N',N'-tetramethyl-ethane-1.2-diamine (TEMED) Sigma-Aldrich, Germany 
Paraformaldehyde Merck, Germany 
PCR buffer II Applied Biosystems, USA 
Penicillin-streptomycin PAA Laboratories, Austria 
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Polyvinylidene difluoride (PVDF) membranes Bio-Rad, USA 
Potassium chloride (KCl) Merck, Germany 
Precision Plus ProteinTM Standards Bio-Rad, USA 
Protease inhibitor cocktail Roche, Germany 
Random hexamers Boehringer, Germany 
Sodium chloride (NaCl) Roth, Germany 
Sodium dodecyl sulphate (SDS) Sigma-Aldrich, Germany 
Sodium hydroxide (NaOH) Merck, Germany 
Tissue Tek O.C.T compound Sakura, Netherlands 
Tris Carl Roth, Germany 
Tween 20 Sigma-Aldrich, Germany 
 
Materials and methods 
____________________________________________________________________________ 
21
2.2 Methods 
2.2.1  Genotyping 
Mouse tail biopsies were obtained and DNA was prepared using the DNeasy extraction kit 
(Qiagen, Germany) according to manufacturer’s instructions. Genotyping was performed with 
the following primer sets detecting wild type 5’-AGT TGA TGT TCA TCT CAG GTG GC-3’ 
(fwd), 5’-GGG TCC TAT AGA TCG AGG TAC C-3’ (rev) and mutated 5-HT2C gene locus 
5’-CAC CTT GCT CCT GCC GAG AAA-3’ (fwd), 5’-AGA AGG CGA TAG AAG GCG 
ATG-3’ (rev). PCR amplification was carried out as describe in details below (see section 
2.2.7), except that cycling conditions were 10 min at 95°C, 35 cycles with 30 s at 94°C, 30 s 
at 57°C, 20 s at 72°C, and a final extension at 72°C for 10 min. PCR products were separated 
by electrophoresis on a 1.5% agarose gel in Tris-acetate-EDTA buffer (Fig. 2.1). Negative 
controls were run by adding H2O instead of the DNA template.  
 
M 1 2 3 4 5 6 7 8 9 H2O
WT
KO
600 bp
600 bp
 
 
Fig. 2.1 PCR genotyping of the 5-HT2C receptor-deficient mice. 
DNA extracted from tail snips was analyzed by PCR with primers detecting wild type (upper 
panel) and mutated version (lower panel) of 5-HT2C gene. Lanes 1-9 show results for 
individual mice. Animals 1, 3, 6, 8, and 9 are carrying the wild type allele. Mice 5 and 7 are 
5-HT2C-deficient, while animals 2 and 4 are heterozygous. H2O = negative control, M = DNA 
marker 
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2.2.2 Isolation of rat alveolar macrophages 
Animals were killed by inhalation of an overdose of isoflurane (Abbott, Germany). The lung 
was carefully removed, cannulated via the trachea, and bronchoalveolar lavage (BAL) was 
performed using 10 x 5 ml ice-cold PBS (PAA, Austria) containing (in mM): KCl 2.68, 
KH2PO4 1.47, NaCl 136.89, Na2HPO4 8.10 (pH 7.3). The lavage fluid was centrifuged at 400 
g for 5 min at 4°C, and the pellet was resuspended in PBS or DMEM/F12 GlutaMax-I 
medium (Invitrogen, Germany) supplemented with penicillin (100 U/ml) and streptomycin 
(0.1 mg/ml). BAL cells were monitored by microscopy, and preparations containing 
erythrocytes were discarded. Cells were purified by adherence for at least 1 h and washed. 
 
2.2.3  Isolation of mouse alveolar macrophages 
BAL fluid was obtained by cannulating the trachea with a shortened 21 G needle attached to a 
1-ml insulin syringe, followed by repeated intratracheal instillations with 500 μl aliquots of 
sterile PBS/2 mM EDTA (pH 7.2) until a BAL fluid volume of 5 ml was recovered. The 
lavage fluid was centrifuged at 400 g for 10 min at 4°C, and the pellet was resuspended in 
PBS, RPMI 1640 or DMEM/F12 GlutaMax-I medium (Invitrogen) supplemented with 
penicillin (100 U/ml) and streptomycin (0.1 mg/ml). Cells were purified by adherence for at 
least 30 min and washed.  
2.2.4 NR8383 cell culture 
The rat NR8383 AM cell line (CRL-2192, ATCC, LGC Standards, UK), was cultured in 
DMEM/F12 medium supplemented with 15% heat-inactivated FCS, penicillin (100 U/ml) and 
streptomycin (0.1 mg/ml) at 37°C and 5% CO2. Before the experiments, cells were 
centrifuged at 400 g for 10 min at 22°C, and the pellet was resuspended in DMEM/F12 
medium. 
 
2.2.5 Flow cytometric analysis 
Cells obtained by BAL were resuspended in PBS/1% BSA and counted using a Neubauer 
chamber. Cells were incubated with directly conjugated monoclonal antibodies (eBiosciences, 
USA), which are listed in Tab. 2.1. Controls were incubated with isotype-matched control 
antibodies. 
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Antibody Clone Isotype Label Amount used for 1 staining [μg] 
CD45 30-F11 Rat IgG2b, κ FITC 0.125 
CD11b M1/70 Rat IgG2b, κ APC 0.05 
CD11c N418 Armenian Hamster IgG PE 0.03 
Gr-1 RB6-8C5 Rat IgG2b, κ PE 0.05 
 
Tab. 2.1 Antibodies used for flow cytometry on mouse cells. 
FITC = Fluorescein isothiocyanate, APC = Allophycocyanin, PE = Phycoerythrin 
 
Staining was performed at 4°C in the dark for 30 min. After staining, cells were washed twice 
in PBS/1% BSA. Samples were acquired using a FACSCalibur flow cytometer equipped with 
an argon-ion laser at 488 nm excitation wavelength and a red-diode laser at 633 nm excitation 
wavelength and CellQuest software (BD, USA), and the data were analyzed with FlowJo 
software (Tree Star, USA).  
 
2.2.6 RNA isolation and cDNA synthesis 
Total RNA was isolated using RNeasy Mini Kit (Qiagen, Germany). RNA was isolated 
following the instructions of the manufacturer and was quantified spectrophotometrically 
using a Biophotometer (Eppendorf, Germany).  
Genomic DNA contaminations were removed by DNAse I (Invitrogen) digestion for 15 min 
at 37ºC, 1 U/reaction. Synthesis of cDNA was performed with iScript (Bio-Rad, Germany) or 
SuperScript II (Invitrogen) kits using 1 µg total RNA. For the iScript cDNA synthesis, the 
following reagents were combined: 
Component Amount per reaction 
5x iScript reaction mix 4 μg 
iScript reverse transcriptase 1 μl 
RNA 1 μg 
H2O up to 20 μl 
 
Conditions for the reaction were 5 min at 25ºC, 30 min at 42ºC, and 5 min at 85ºC.  
 
Materials and methods 
____________________________________________________________________________ 
24
Alternatively, mRNA was reversely transcribed using SuperScript II kit. For the reaction, the 
following reagents were combined: 
Component Amount per reaction 
mRNA 1 µg 
Oligo d(T) (500 μg/ml) 1 µl 
dNTP mix (10 mM each) 1 µl 
H2O Up to 12 µl 
 
To anneal oligo d(T) primers to mRNA, reagents were mixed, heated to 65ºC for 5 min, and 
quickly chilled on ice. Then, 5X First-Strand Buffer (4 µl) and 0.1 M DTT (2 µl) were added 
to the tube. Components were mixed and incubated 2 min at 42ºC. Superscript II reverse 
transcriptase was added (1 µl) and reagents were mixed by gentle pipeting. The tube was 
incubated at 42°C for 50 min. The reaction was terminated by heating up the components to 
70°C for 15 min. After synthesis, cDNA was stored in -20ºC. 
Materials and methods 
____________________________________________________________________________ 
25
2.2.7 RT-PCR 
The cDNAs were amplified with the subunit specific primer pairs spanning at least one intron 
(for primers detecting rat sequences, see Tab. 2.2 mouse primers are listed in Tab. 2.3). 
Target Sequence Length 
Gene Bank 
Accession No. 
for. AGCTCACCGCTGTCCTCCT nAChR α1 
rev. GGATCAGTTGCAGTCCCACA 
171 bp NM_024485 
for. CGCGTCCCTTCAGAGATGAT nAChR α2 
rev. CACAGTGCCCGTGAAGAA 
114 bp L31622 
for. CCTCCCTGTCTATCGGGTCT nAChR α3 
rev. GCCGGATGATCTCGTTGTAA 
161 bp X03440 
for. GGACCCTGGTGACTACGAGA nAChR α4 
rev. CATAGAACAGGTGGGCCTTG 
137 bp NM_024354 
for. TGGAACACCTGAGCGACAAG nAChR α5 
rev. CGTGACAGTGCCGTTGTACC 
284 bp NM_017078 
for. TGGTGTTAAGGACCCCAAAA nAChR α6 
rev. GCTGCTGGCTTAACCTCTTG 
142 bp NM_057184 
for. ACATTGACGTTCGCTGGTTC nAChR α7 
rev. CTACGGCGCATGGTTACTGT 
235 bp L31619 
for. CGTGGGATCGAGACCAGTAT nAChR α9 
rev. TCATATCGCAGCACCACATT 
142 bp AY574257 
for. GTGCCACTCATCGGAAAGTA nAChR α10 
rev. TGTGCATTAGGGCCACAGTA 
107 bp NM_022639 
for. TCCTAAGCGTGGTGGTCCTC nAChR β1 
rev. TGTGGTTCGGGTAGTTGGTC 
151 bp NM_01258 
for. AGCCTTCTTTGGCTGTGCTC nAChR β2 
rev. GAGCCGTTAGTAGCTGGACGA 
116 bp NM_019297 
for. CACTCTGCGCTTGAAAGGAA nAChR β3 
rev. GCGGACCCATTTCTGGTAAC 
196 bp NM_133597 
for. CACTCGCGGTTCCATTGTAG nAChR β4 
rev. CGGGTTTTGTTCAGGAGGTC 
159 bp NM_052806 
for. AGGAAAGCTTCCAGGAGGAG P2Y1 
rev. GGCCAATAGAATGTTGCTTCTT 
203 bp NM_012800 
for. CATGCGAGTGAAGAACTGGA P2Y2 
rev. GGCAGCAGCACATACTTGAA 
209 bp NM_017255 
for. AGTCCCTGGGCTGGACTAAG P2Y4 
rev. GTGTCTGACAATGCCAGGTG 
267 bp NM_031680 
for. TCCCAGCGTCGTGATTAGTG HPRT1 
rev. TCCAGCAGGTCAGCAAAGAA 
225 bp NM_012583 
 
Tab. 2.2 Rat primer sequences used in the study.  
Sequences for forward (for.) and reverse (rev.) primers are given in 5`→3` order. 
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Target Sequence Length 
Gene Bank 
Accession No. 
for ATAGCCGCTTCAACTCCAGA 5HT2A 
rev TCATCCTGTAGCCCGAAGAC 
106 bp NM_172812.1 
for GGGCTACTGCATTCATCAAGA 5HT2B 
rev CTCACAGGTGACATTGTGTGG 
119 bp NM_008311.2 
for GTTCAATTCGCGGACTAAGG 5HT2C 
rev TCACGAACACTTTGCTTTCG 
116 bp NM_008312.4 
for ACAATACTTCGCCAGCACCA nAChR α7 
rev AAACCATGCACACCAGTTCA 
144 bp AF225980 
for CAATGCTCTGCGTCCAGTAG nAChR α9 
rev ACACCAGATCGCTGGGAATC 
209 bp XM_132045 
for TCTGCTCCTGCTCTTTCTCC nAChR α10 
rev CCACAGGTACAAGGTCAGCA 
208 bp XM_89067 
for GAGTGTGAGGGAGGATTGGA nAChR β2 
rev TCGTGGCAGTGTAGTTCTGG 
139 bp AY574268 
for CAGCCCATCCAACCTCTATG nAChR β4 
rev CTGACGCCCTCTAATGCTTC 
156 bp NM_148944 
for ACCCTGGTCTTTCTGGTGCT β-MG 
rev AATGTGAGGCGGGTGGAA 
150 bp NM_009735 
 
Tab. 2.3 Mouse primer sequences used in the study.  
Sequences for forward (for.) and reverse (rev.) primers are given in 5`→3` order. 
 
Hypoxanthine guanine phosphoribosyl transferase 1 (HPRT1) or beta microglobulin (β-MG) 
primers were used to monitor cDNA integrity. For one reaction, the following reagents were 
combined: 
Component Volume per reaction 
PCR buffer II (100 mM Tris-HCl, 500 mM KCl, pH 8.3) 2.5 µl 
MgCl2 (15 mM) 2 µl 
dNTP (10 mM each) 0.6 µl 
forward and reverse primer (10 µM each) 0.6 µl 
ApliTaq Gold polymerase (5 U/µl) 0.125 µl 
DNA or cDNA 1 µl 
H2O up to 25 µl 
 
Cycling conditions were 10 min at 95°C, 35 cycles with 30 s at 94°C, 30 s at 57-60°C, 20 s at 
72°C, and a final extension at 72°C for 10 min.  
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PCR products were separated by electrophoresis on gels prepared with 1x Tris-acetate-EDTA 
buffer + 1.5 % agarose (Peqlab, Germany) + 0.5 mg/ml ethidium bromide. Tris-acetate-EDTA 
buffer was prepared as a 50x Tris-acetate-EDTA stock (pH 8.0). For 50x Tris-acetate-EDTA, 
242 g Tris base, 75.1 ml glacial acetic acid, and 37.2 g Na2EDTA were dissolved in H2O and 
the volume was adjusted to 1000 ml with H2O. 
Electrophoresis was run at a constant voltage of 150 V for 30 min. PCR products were 
visualized under UV light and documented using a gel documentation system (Phase, 
Germany). An 100 bp DNA marker (Fermentas, USA) served as marker for PCR product size. 
Positive controls for primers were run by using reversely transcribed total RNA from tissues 
abundantly expressing the respective target sequences (Tab. 2.2). 
 
Target Positive control 
nAChR subunits α2-α10 DRGa, brainb 
nAChR subunits α1, β1 Skeletal muscle 
nAChR subunits β2-β4 Lung 
P2Y1,2,4,6  receptors Spleen 
5-HT2A,B,C receptors Brain 
 
Tab. 2.4 Tissues used as positive controls for RT-PCR reaction with target-specific 
primers  
a for primers specific to rat sequences b for primers specific to mouse sequences. 
 
Synthesis of primers and sequencing of PCR products was done by MWG Biotech 
(Ebersbach, Germany). Negative controls were performed by omitting the reverse 
transcription step or by using H2O instead of cDNA template. 
2.2.8 Immunofluorescence 
Lavaged cells were plated on polystyrene 8-well culture slides (BD Biosciences, Belgium) in 
DMEM/F12 supplemented with penicillin (100 U/ml) and streptomycin (0.1 mg/ml). Cells 
were allowed to attach for 2 h, fixed in acetone (-20°C, 10 min) or isopropanol (4°C, 10 min) 
and air-dried for 1 h.  
Shock-frozen lung specimens were prepared by immersion in freezing isopentane with O.C.T. 
compound (Sakura, Netherlands) cryoprotection. Cryostat sections were cut at 10 µm 
thickness, fixed as above and subjected to indirect immunofluorescence using antisera 
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directed against nAChR subunits and monoclonal antibody ED1 [93], directed to a CD68-like 
antigen expressed by AM (Serotec, Germany). For the detection of the 5-HT2C receptor in 
mouse lung cryostat sections, a goat polyclonal antibody (sc-15081, Santa Cruz, USA) was 
used. Detailed information on the antibodies is provided in Tab. 2.5.  
 
Target Immunogen Host Dilution Source 
nAChR α3 
Synthetic peptide (aa 466-474 of human 
sequence)a 
Rabbit 1:1600 Acris 
nAChR α4 Synthetic peptide (620-627, human) a Rabbit 1:800 Acris 
nAChR α5 Synthetic peptide (460-468, human) a Rabbit 1:1600 Acris 
nAChR α7 Synthetic peptide (493-502, human) a Rabbit 1:1000 Acris 
nAChR α7 
Native and denatured α7 subunit (380-400, 
chicken) and denatured α7 subunit from rat 
Mouse, 
monoclonal, 
clone mAb 
306 
1:750 Sigma-Aldrich 
nAChR α9 Synthetic peptides (81-97 and 115-128, rat) Guinea-pig 1:1000 
Kurzen et. al. 
[94] 
Synthetic peptide (404-418, rat) a Rabbit 1:2000 
nAChR α10 
Synthetic peptide  (404-418, rat) a Guinea-pig 1:4000 
Own, Lips et. 
al. [95] 
nAChR β2 Synthetic peptide (493-502, human) a Rabbit 1:1600 Acris 
nAChR β3 Synthetic peptide (450-458, human) a Rabbit 1:800 Acris 
nAChR β4 Synthetic peptide (490-498, human) a Rabbit 1:3200 Acris 
CD68-like Rat spleen cells 
Mouse, 
monoclonal, 
clone ED1 
1:800 Serotec 
sc-15081 
Syntetic peptide (mapping N-terminus, 
human)a 
Goat 1:100 Santa Cruz 
 
Tab. 2.5 Primary antibodies used in the study.  
Origin and regions of nAChR subunits and 5-HT2C receptor sequences used for generation of 
the antibodies are provided in brackets. aPeptides available for preabsorption. 
Materials and methods 
____________________________________________________________________________ 
29
Unspecific binding sites were saturated with 50% normal horse serum in PBS for 1 h, 
followed by overnight incubation with the primary antibody, washing (3 x 10 min) and 
application of the secondary antibody (Tab. 2.4) for 1 h. In some preparations, cell nuclei 
were stained with DAPI (Sigma-Aldrich) (10 min, 1 μg/ml). Slides were washed, fixed in 
buffered 4% paraformaldehyde, coverslipped in carbonate-buffered glycerol (pH 8.6) and 
examined with a Zeiss Axioplan 2 microscope (Zeiss, Germany) and a confocal laser 
scanning microscope (CLSM, TCS SP2, Leica, Germany) using argon and HeNe lasers 
equipped with appropriate filter sets. 
 
Immunogen Host Dilution Source Fluorochrome Format  
rabbit Ig donkey 1:2000 Chemicon,  
Germany 
Cy3 IgG 
guinea pig Ig donkey 1:800 Dianova, 
Germany 
Cy3 IgG 
mouse Ig donkey 1:400 Dianova FITC Ig 
guinea pig Ig donkey 1:400 Dianova Texas Red Ig 
goat Ig donkey 1:1000 Chemicon Cy3 Ig 
 
Tab. 2.6 Secondary antibodies used in the study. 
 
Positive controls were run on shock-frozen and acetone-fixed DRG, brain or gut sections. The 
specificity of the immunolabeling was validated by omission of the primary antibody or 
preincubation with the corresponding antigen. Preabsorption was done by mixing antibodies 
with the peptide used for immunization (14-24 μg peptide per 100 µl of antibody solution) for 
1 h before application on slides. Peptides were obtained from the same source as the 
antibodies (Table 2.3). Suitability of the sc-15081 antibody was tested by immunolabeling of 
cryostat sections of 5-HT2C receptor-deficient and wild-type mice lungs. 
 
2.2.9 SDS polyacrylamide gel electrophoresis and immunoblotting for nAChR α7 and α10 
subunits detection 
Snap-frozen BAL cells, rat brain and skin samples were homogenized and boiled in 
Laemmli's sample buffer containing: 
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Component Concentration 
1 M Tris-Cl pH 6.8 62.5 mM 
Glycerol 10% (v/v) 
β-Mercaptoethanol 4% (v/v) 
Sodium dodecyl sulfate 2.3% (m/v) 
Bromophenol blue 0.001% (m/v) 
Complete® protease inhibitor cocktail 1 x 
 
SDS polyacrylamide gel electrophoresis (SDS-PAGE) was done in 1 x SDS-running buffer 
(90 mA for 1.5 h). Gels were composed of 5% stacking gel and 15% separating gel according 
to Laemmli [96]. 
1 x SDS running buffer 
Component Concentration 
Tris base 25 mM  
Glycine 250 mM  
SDS 0.1% (v/v)  
 
Stacking gel 5 % 
Component Concentration 
Tris (pH 6.8) 125 mM 
Acrylamid 5 % 
SDS 0.1% (w/v) 
Temed 0.1%(v/v) 
APS 0.1% (w/v) 
 
Separating gel 15 % 
Component Concentration 
Tris (pH 8.8) 375 mM 
Acrylamid 15 % 
SDS 0.1% (w/v) 
Temed 0.1%(v/v) 
APS 0.1% (w/v) 
Samples (5 x 104 cells) and Rainbow™ colored molecular mass markers (Amersham 
Pharmacia Biotech, Germany) were separated on the same gel. Proteins were transferred 
electrophoretically onto Immobilon™-P PVDF membranes (Millipore, USA) using a blotting 
buffer consisting of 25 mM Tris, 192 mM glycine, 20% (v/v) methanol and 0.05% (w/v) SDS. 
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Membranes were pre-incubated with PBS containing 10% (v/v) Rotiblock (Roth, Germany) 
solution for 1 h. Primary mouse-anti-nAChR α7 antibodies (1:1000, clone mAb 306, Sigma-
Aldrich, Germany) were diluted in blocking solution and incubated with membranes 
overnight at 4°C. For the detection of α10 subunits, membranes were pre-incubated with PBS 
containing 5% (w/v) non-fat milk powder (Roth) and guinea pig-anti-nAChR α10 (1:4000, 
[95]) antibodies were used. Blots were washed in PBS, 0.05% (w/v) Tween 20, and bound 
primary antibodies were detected by horseradish peroxidase-conjugated immunoglobulins 
(DAKO, Germany) in PBS, 2% low fat milk, 0.05% Tween 20 (TPBS). Secondary antisera 
were rabbit anti-mouse IgG (1:5000 in TPBS + 1% normal rat serum) and rabbit-anti-guinea 
pig IgG (1:5000 in TPBS + 2% low fat milk). Peroxidase activity was visualized by 
SuperSignal® West Pico Chemiluminescent Substrate (Pierce, USA) using the Kodak 
Scientific Imaging Film X-OMAT™ LS (Eastman Kodak, USA). Gels and blots were 
documented and densitometrically analyzed using a digital gel documentation system 
(Biozym, Germany). 
 
2.2.10 Intracellular calcium concentration measurements 
Recordings of [Ca2+]i were performed after 3-8 h in primary culture (n=3 animals and 10-12 
coverslips for each experimental setup). Experiments with NR8383 cells were done after 2-4 
h in culture (n=3). Measurements were done in Hepes buffer. 
 
Hepes buffer 
Component Concentration [mM] 
KCl  5.6 
NaCl  136.4 
MgCl2  1 
CaCl2  2.2 
D-glucose  11 
Hepes  10 
 
In some experiments, CaCl2 was omitted from the buffer composition and the buffer was 
supplemented with EGTA (3 x 10-6 M). Cells were loaded for 30 min with fura-2 AM (3.3 x 
10-6 M, Invitrogen) and washed 3 x 10 min. Measurements were done in Hepes buffer at a 
constant temperature of at 34 °C. Fluorescence images were taken with a slow scan CCD 
camera system with fast monochromator (TiLL Photonics, Germany) coupled to an inverted 
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microscope with 20x and 40x water immersion objectives (Olympus, Germany). Fura-2 was 
excited at 340 and 380 nm wavelengths (λ), and fluorescence was collected at λ>420 nm. 
Each cell was independently tracked, and the fluorescence intensity ratio of 340/380 nm was 
recorded. Viability of the cells was monitored after measurements with Trypan Blue 
exclusion. Ratio values were normalized to 100% at the beginning of the recording. Curves 
were plotted from recordings done in preparations from n≥3 animals. Data are shown as 
mean±SEM. 
 
2.2.11 Drugs 
Drugs were dissolved in double distilled water or Hepes buffer as 10-2-10-4 M stock solutions 
and stored in aliquots at -20°C. All solutions were pre-warmed to 37°C before use. 
 
 
Tab. 2.7 Drugs used in the study.  
 
2.2.12 Dot-blot based mouse cytokine antibody array 
Mouse AM were cultured in RPMI 1640 medium containing 1% BSA, L-glutamine, and 
penicillin/streptomycin at 5 x 105 cells/well in 24-well tissue culture plates. Cells were 
stimulated with 10-5 M 5-HT for 24 h. In controls, 5-HT was omitted from the media. Culture 
supernatants were used for qualitative measurement of cytokine expression using the Mouse 
Cytokine Antibody Array, Panel A (ARY006), as recommended by the manufacturer (R&D 
Systems, Germany). 
Drug Action 
Concentration 
[M] 
Source 
Adenosine 5′-triphosphate 
di(tris) salt dihydrate (ATP) 
Agonist at P2Y, P2X receptors 10-4 Sigma-Aldrich
Epibatidine Agonist at neuronal type nAChR 10-6 Sigma-Aldrich
Nicotine hydrogen tartrate Agonist at nAChR 10-4 Sigma-Aldrich
α-bungarotoxin 
Antagonist at nAChR α7 and 
α9/α10 10
-7 Sigma-Aldrich
5-hydroxytryptamine (5-HT) Agonist at 5-HTR 10-5 Sigma-Aldrich
RS102221 Antagonist at 5-HT2C receptor 10-8 Tocris 
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2.2.13 Statistical analysis 
Data in the figures and text are expressed as mean±SEM. Recordings of [Ca2+]i were 
statistically analyzed by comparing the differences in Fura-2 ratio before and after addition of 
test substance, among different treatment groups. The non-parametric rank based Kruskal-
Wallis test was used to compare multiple groups, and if significant differences were detected, 
it was followed by Mann-Whitney test to compare between two experimental groups. Tests 
were performed using SPSS software (SPSS software, Germany). P≤0.05 was considered 
significant and P≤0.01 as highly significant. 
 
2.3 Experimental protocols 
2.3.1 Rat alveolar macrophages 
Cells were exposed to nicotine (10-6-10-4 M) or epibatidine (10-6 M). Controls were performed 
with vehicle treatment. Two min after administration of nicotine or epibatidine, cells were 
stimulated with ATP (10-4 M). In some experiments, cells were exposed to nicotine in the 
presence of the nAChR α7 and α9/α10 blocker α-bungarotoxin (10-7 M). Measurements were 
done in buffer with or without calcium, as indicated. Cells that did not respond to ATP by an 
at least 5% change in [Ca2+]i were excluded from further analysis.  
2.3.2 Mouse alveolar macrophages  
Cells were exposed to 5-HT (10-5 M) or ATP (10-4 M) alone or in the presence of nicotine, 
given 2 min prior to agonist. In some experiments, the extracellular buffer lacked calcium and 
was supplemented with EGTA (3 x 10-6 M). In an other set of experiments, AM were pre-
incubated with the 5-HT2C receptor blocker RS102221 compound (10-8 M) for 2 min and then 
were stimulated with 5-HT (10-5 M). Controls were performed with 1) vehicle treatment, and 
2) ATP (10-4 M) serving as a positive control. Cells that did not respond to 5-HT or ATP by 
an at least 5% change in [Ca2+]i were excluded from further analysis. 
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3 Results 
3.1 Expression of nAChR on freshly isolated rat alveolar macrophages 
3.1.1 Purity of isolation 
To assess purity of isolation of rat AM, indirect immunofluorescence labeling was performed. 
The vast majority of BAL cells showed strong staining with ED1 antibody, an AM marker 
[93].  
 
 
Fig. 3.1 Purity of isolated rat AM. 
(A) Cells were immunolabeled with ED1 antibodies, an AM marker. (B) Merged image where 
nuclei of all cells present in the preparation were stained with DAPI. The majority of cells 
show a strong ED1 staining. Rare ED1-negative cells are indicated by arrows. Negative 
controls (neg. contr.) were done by omission of the primary antibody. Bar: 20 µm 
 
3.1.2 Expression of nAChR analyzed by RT-PCR 
RT-PCR analysis of mRNA isolated from BAL cells revealed expression of nAChR subunits 
α2, α3, α5, α9, α10, β1, and β2. Products corresponding to the α4, α6, α7, and β3 subunits 
were never found in BAL cells (Fig. 3.2), although they were easily detectable in DRG and 
lung homogenate. The mRNAs of subunits α9, α10, β1, and β2 were consistently expressed. 
Subunits α2, α3, and β4 were detected in 1 out of 9 preparations. Subunit α5 was present in 3 
out of 9 preparations. The identity of amplified products was confirmed by sequencing, and 
control runs without template were negative. 
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Fig. 3.2 RT-PCR analysis of nAChR subunits in rat BAL cells. 
BAL cells consistently express mRNA coding for α9, α10, β1 and β2 subunits. Subunit α5 has 
an interindividual expression pattern, as shown in the two different BAL samples. The 
mRNAs coding for α1, α4, α6, α7 and β3 subunits are absent. Positive controls were run on 
DRG (α2-α10), lung (β2-4), and skeletal muscle (α1 and β1). Negative controls were done 
without RT. M = DNA marker 
 
3.1.3 Immunocytochemistry for nAChR 
Expression of nAChR receptors was assessed by immunocytochemistry. ED1-positive cells 
were immunoreactive for α9 and α10 nAChR subunits, and in 50% of BAL preparations (5 
out of 10 samples) for the α5 subunit as well (Fig. 3.3). Preabsorption with the synthetic 
peptides used for immunization resulted in absence of immunolabeling for α5 and α9 
subunits. Specificity of α10 nAChR subunit antibody was tested by western blotting (see 3.1.4 
and Fig. 3.7). Staining was predominantly intracellular, localized near the nucleus, except for 
α5 and α9 subunit-immunoreactivity that exhibited a punctate surface distribution in a subset 
of AM (Fig. 3.3, inserts). The rabbit polyclonal antibody to α7 subunit faintly stained AM, but 
preabsorption with the corresponding peptide gave the same staining pattern. The monoclonal 
antibody to the α7 nAChR subunit (mAb 306) did not show any labeling of AM. Positive 
controls were run on DRG sections, demonstrating labeling of neuronal cell bodies with mAb 
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306 (Fig. 3.4). Similar staining patterns with antisera directed against nAChR subunits were 
observed in rat lung sections (Fig. 3.4). Here, the antiserum against the α9 nAChR subunit 
showed marked punctuate membrane staining of AM (Fig. 3.4, insert). There was no specific 
labeling for subunits α3 and α4 in ED1-positive cells. 
 
Immunofluorescence with antisera directed against β2 and β3 nAChR subunits showed strong 
staining of ED1-positive BAL cells, while antibodies to the β4 subunit gave faint staining 
(Fig. 3.5A). Similar staining patterns were noted in rat lung sections, but preabsorption 
controls with peptides corresponding to β3 and β4 nAChR subunits gave the same signal 
intensity in ED1-positive cells (Fig 3.5B). Preabsorption control for β2 nAChR antibodies 
showed slighty less intense labeling of AM (Fig. 3.5B). 
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Fig. 3.3 Double-labeling immunofluorescence for nAChR α-subunits 
demonstrating the presence of the nAChR subunits α5, α9 and α10 in ED1-positive BAL 
cells. A punctate fluorescence pattern for the α5 and α9 nAChR subunits was found in a 
subset of AM (inserts). Negative results were noted for α3, α4 and α7 subunits in ED1-
positive cells, despite occasional occurrence of α3 subunit immunoreactive ED1-negative 
cells (arrow). Negative controls (neg. contr.) were done by omission of the primary antibody. 
Preabsorption (preabs.) was done by incubation of the primary antibody with the peptide used 
to raise the antibody. Bar: 20 µm, 10 µm in inserts. 
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Fig. 3.4 Immunohistochemistry for nAChR α-subunits on rat lung and DRG sections. 
The mAb 306 directed against the α7 subunit fails to label AM (A, arrow) but it stains nerve 
cell bodies (B, arrows) in DRG sections serving as a positive control. Arrowheads: Elastin 
autofluorescence in alveolar septum. The antibodies to α9 (C) and α10 (D) subunits label 
ED1-positive AM in alveoli. The insert demonstrates punctate α9 subunit immunoreactivity in 
a CLSM optical section. Negative controls (neg. contr.) were done by omission of the primary 
antibody. AS = alveolar septum. Bar: 20 μm 
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Fig. 3.5 Double-labeling immunofluorescence with antibodies for nAChR β-subunits. 
Antisera directed against β2, β3 and β4 reacted with ED1-positive cells in BAL samples (A) 
and rat lung sections (B). However, labeling could not be fully preabsorbed with peptides 
used to generate the antibodies. Negative controls (neg. contr.) were done by omission of the 
primary antibody. Preabsorption (preabs.) was done by incubation of the primary antibody 
with the peptide used to raise the antibody. Bar: 20 μm 
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3.1.4 Western blotting 
Western blotting supported the immunohistochemical findings in that the mAb 306 failed to 
detect the α7 subunit in protein preparations from BAL cells while it recognized a ~50 kDa 
band in protein extracts from rat brain (Fig. 3.6). In Western blots of rat skin homogenates 
serving as a positive control, a single 67-kDa protein was recognized utilizing a previously 
characterized antiserum directed against the α10 nAChR subunit [95]. As shown in Fig. 3.6, 
this band plus additional bands at 110-130 kDa were immunolabeled in protein preparations 
from BAL cells.  
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Fig. 3.6 Immunoblots.  
No α7 subunit-immunolabeling is present in BAL samples, while the antibody mAb 306 
recognizes a single 50 kDa protein band in protein extracts from rat brain. Affinity purified 
polyclonal antibodies to α10 nAChR label a protein band at 67 kDa in BAL cells and rat skin 
samples. In BAL cells, additional bands at 110-120 kDa are immunolabeled. 
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3.2 Functional analysis of nAChR in rat alveolar macrophages 
3.2.1 ATP-triggered increase in Ca2+ derives from intracellular stores 
In freshly isolated rat AM, ATP (10-4 M) induced a rise in [Ca2+]i which reached maximum 
within 10 s after drug addition, and was followed by a slow decrease. Exclusion of calcium 
ions from the external solution had no effect on the maximal amplitude of the ATP-induced 
[Ca2+]i rise (46% for +Ca2+ and 47% for –Ca2+ Hepes buffer). Macrophages exposed to 
extracellular Ca2+  showed a sustained increase in [Ca2+]i whereas cells stimulated in Ca2+-free 
buffer showed only a transient rise without reaching a phase of elevated [Ca2+]i (P≤0.001) 
(Fig. 3.7A). The percentage of cells reacting to the ATP stimulus was decreased from 58% in 
Ca2+-containing to 18% in Ca2+-free buffer (582/1012 cells in +Ca2+ vs 197/1085 cells in –
Ca2+ buffer). To better understand which receptors might be involved in ATP-induced [Ca2+]i 
rise, we performed RT-PCR analysis and found P2Y1, P2Y2 and P2Y4 purinergic receptor 
mRNAs in AM (Fig. 3.7B). 
 
3.2.2 Nicotine modulates ATP-induced rise in [Ca2+]i 
We tested whether nicotine modulates [Ca2+]i levels. Half of the macrophage population 
(131/261 cells) exposed to ATP showed a transient rise in [Ca2+]i (increase by 47%). 
Application of nicotine (10-6, 10-5, 10-4 M) or epibatidine (10-6 M) had no direct effect on 
[Ca2+]i. Nicotine given 2 min prior to ATP reduced the ATP-induced calcium peak by 38% 
(P≤0.006), while not changing the percentage of cells reacting to the ATP stimulus (54%, 
120/222 cells). Epibatidine was neither effective in reducing ATP-induced transients nor it 
changed the percentage of cells reacting to the ATP (51%, 117/230 cells) (Fig. 3.8A).  
In a separate set of experiments, we tested if the effect of nicotine can be blocked with the α1, 
α7 and α9/α9α10 nAChR antagonist α-bungarotoxin. This drug alone (10-7 M) had no effect 
on ATP-induced calcium increase, when compared to vehicle control, but it abrogated the 
effects of nicotine (P≤0.001). The transient rise in [Ca2+]i in cells treated with α-bungarotoxin 
together with nicotine was slightly increased compared to vehicle-treated cells (P≤0.025) (Fig. 
3.8). 
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Fig. 3.7 Purinergic receptors on freshly isolated BAL cells. 
ATP-induced transients in [Ca2+]i are mainly dependent on intracellular stores. (A) 
Ratiometric [Ca2+]i recordings. BAL cells were stimulated with ATP (10-4 M) in the presence 
or absence of extracellular Ca2+. Sustained increase, but not initial rise in [Ca2+]i is dependent 
on extracellular Ca2+. Number of cells which reacted, and total number of measured cells are 
given in brackets. Differences in signal intensity immediately before, and after 10 s or 1 min 
following the application of ATP were tested for significance. n.s. = not significant, 
***P≤0.001. (B) RT-PCR in rat BAL cells shows expression of P2Y1, P2Y2 and P2Y4 
purinergic receptors. 
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Fig. 3.8 Nicotine dampens ATP-induced increase in [Ca2+]i.  
Ratiometric [Ca2+]i recordings. (A) BAL cells were stimulated with ATP (10-4 M) in the 
presence or absence of nicotine (10-4 M) or epibatidine (10-6 M). ** P≤0.01 (nicotine 
compared to Hepes) (B) The reduction of ATP-induced rise in [Ca2+]i by treatment with 
nicotine is blocked by pre-incubation with the nicotinic antagonist α-bungarotoxin (10-7 M). 
***P≤0.001 (nicotine compared to α-bungarotoxin + nicotine), #P≤0.05 (Hepes compared to 
α-bungarotoxin + nicotine). Number of cells which reacted, and total number of measured 
cells are given in brackets. Differences in Fura-2 ratio immediately before and 10 s after the 
application of ATP were tested for significance. 
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Fig. 3.9 Nicotine-mediated effect on ATP-induced [Ca2+]i rise is not depended on 
extracellular calcium. 
Ratiometric [Ca2+]i recordings. BAL cells were treated with nicotine (10-4 M) or with the 
vehicle in the presence of extracellular Ca2+. BAL cells were pre-treated with nicotine or with 
the vehicle, and then stimulated with ATP (10-4 M). Number of cells which reacted, and total 
number of measured cells are given in brackets. Differences in Fura-2 ratio immediately 
before and 10 s after the application of ATP were tested for significance. ***P≤0.001. 
 
3.2.3 Nicotinic modulation is not dependent on extracellular calcium 
Next we tested if the nicotine-mediated effect upon the ATP-induced [Ca2+]i rise is depended 
on extracellular calcium. Immediately before measurements, cells were transferred to Ca2+-
free buffer. In this condition, a constant decrease in [Ca2+]i can be observed. Cells treated with 
nicotine (10-4 M) 2 min before the ATP stimulus showed a decreased amplitude of the ATP-
induced rise in [Ca2+]i. This was not affected by the absence of Ca2+ in the external bath 
solution (Fig. 3.9). The number of cells reacting to ATP was reduced when Ca2+ was omitted 
in the external solution (18% for vehicle and 16% for nicotine treated cells) compared to 
Ca2+-supplemented medium (42% for vehicle and 39% for nicotine treated cells). 
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3.3 Expression of 5-HT receptors and nAChR on freshly isolated mouse alveolar 
macrophages 
3.3.1 Purity of isolated mouse alveolar macrophages 
The majority of isolated BAL cells was identified as leukocytes by CD45 staining (Fig. 
3.10B). These cells were CD11c+ and CD11b- (94.4%±3.35% of CD45+ cells). There was a 
small fraction of CD11c+/CD11b+ cells in BAL (Fig. 3.10C). 
 
Fig. 3.10 Flow cytometry on BAL cells recovered from mouse lung.  
Cells were gated as in (A) based on size and granularity (G1) and subjected to CD45-FITC 
staining (B). CD45+ cells were gated (G2) and further analyzed using CD11c and CD11b 
antibodies. Results are representative of n=4 experiments. 
 
3.3.2 Expression of 5-HT receptors assessed by RT-PCR 
All analyzed BAL samples expressed mRNA for the 5-HT2C receptor. A faint bands 
corresponding to 5-HT2A and 5-HT2B receptor mRNAs were found in 3 out of 5 preparations. 
(Fig. 3.11).  
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Fig. 3.11 Expression of 5-HT2-receptors in mouse BAL cells. 
All tested BAL preparations were positive for 5-HT2C receptor mRNA. The 5-HT2A and 5-
HT2B receptors were found to be expressed in 3 out of 5 samples. Brain was used as a positive 
control. M = DNA marker. 
 
3.3.3 Expression of nAChR analyzed by RT-PCR 
Freshly isolated mouse AM expressed mRNAs for nAChR subunits α9, β2 and β4 (Fig. 3.12). 
Messenger RNA for α10 subunit was found to be present in 2 out of 5 preparations. Products 
corresponding to the α7 subunits were never found in BAL cells (Fig. 3.12), although they 
were easily detectable in brain homogenate, serving as a positive control. 
 
 
 
Fig. 3.12 RT-PCR analysis of nAChR subunits in mouse BAL cells. 
BAL cells consistently express mRNAs coding for α9, β2 and β4 subunits. Expression of α10 
subunit was seen in 2 out of 5 samples. The mRNA for α7 subunit was not found in AM 
preparations, although it is easily detectable in brain homogenate, serving as a positive 
control. M = DNA marker 
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3.3.4 Suitability of the 5-HT2C receptor antibody for immunohistochemistry 
Previous reports suggested sc-15081 antibody as being specific for 5-HT2C receptors [97]. The 
suitability of this antibody was tested by immunolabeling of cryostat sections of 5-HT2C 
receptor deficient and wild-type lungs. The antiserum produced identical 
immunohistochemical labeling patterns in tissues taken from wild-type and 5-HT2C receptor-
deficient mice (Fig. 3.13).  
 
5-HT2C-KO5-HT2C-WT
 
 
Fig. 3.13 Immunohistochemistry with sc-15081 antibody on mouse lung cryostat 
sections. 
Identical pattern of labeling was observed in AM (arrows) from wild-type (5-HT2C-WT) and 
5-HT2C receptor-deficient (5-HT2C-KO) mice. Bar: 20 μm. 
 
3.4 Function of 5-HT receptors and nAChR on freshly isolated mouse alveolar 
macrophages 
3.4.1 5-HT potently stimulates [Ca2+]i rise 
In freshly isolated mouse AM, 5-HT (10-5 M) induced an immediate rise in [Ca2+]i reaching 
its maximum in 6 s, followed by a brief, 15 s decrease and subsequent phase of increased 
[Ca2+]i level (> 5 min). This effect was compared to that of a stimulation with ATP (10-4 M), 
an agonist of P2Y receptors expressed on AM [23]. Treatment with ATP resulted in a lower 
and shorter rise in [Ca2+]i (Fig. 3.15A).  
To examine the requirement of extracellular Ca2+ for rise in [Ca2+]i,, AM were exposed to 5-
HT in Ca2+-free buffer. Alveolar macrophages exhibited only a transient rise without reaching 
a plateau phase (Fig. 3.15B). The peak increase in response to 5-HT was reduced by 35% in 
Ca2+-free buffer when compared to Ca2+-containing buffer. Accordingly, the ratio of Fura-2 
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340/380 nm fluorescence measured at the beginning of the recordings was lower by 23% in 
cells bathed in Ca2+-free buffer (179±3 in Ca2+-containing vs. 139±2 in Ca2+-free buffer,  
P≤0.001). 
We evaluated if 5-HT induces an increase in [Ca2+]i in rat NR8383 AM cells. Responses to 5-
HT (10-8-10-5 M) were tested in n=3 cell preparations. We used a range of experimental 
designs (different agonist concentration, agonist given alone or in series of increasing 
concentration, preparation of cells which were cultured in medium containing 10% FCS or 
10% dialysed FCS). It was unfeasible to group the data from all experiments; therefore a 
representative result is provided. Cells responded very weakly to 5-HT (10-5 M), while ATP 
induced a rapid elevation of [Ca2+]i (Fig. 3.15).  
 
3.4.2 Nicotine dampens 5-HT- and ATP-induced [Ca2+]i rise 
We tested if nicotine modulates [Ca2+]i in mouse AM. Application of nicotine (10-4 M) had no 
direct effect on [Ca2+]i. Nicotine given 2 min prior to 5-HT and ATP, reduced the agonist-
induced calcium peak by 19% and 9%, respectively (P≤0.001) (Fig. 3.16). 
 
Results 
____________________________________________________________________________ 
49
80
100
120
140
160
180
200
220
0 20 40 60 80 100 120 140 160 180 200 220 240
with calcium n=463 cells
without calcium +EGTA n=313 cells
80
90
100
110
120
130
140
150
160
170
180
0 20 40 60 80 100 120 140 160 180 200 220 240 260
Hepes 5-HT (425)
Hepes ATP (311)
Fu
ra
-2
 3
40
/3
80
 n
m
 ra
tio
[%
]
time [s]
5-HT 10-5 M / ATP 10-4 M
Hepes
***
***
5-HT (425/489)
ATP (311/363)
A
Fu
ra
-2
 3
40
/3
80
 n
m
 ra
tio
[%
]
time [s]
***
5-HT 10-5 M
B
with calcium (463/522)
without calcium ( 13/397)
Fu
ra
-2
 3
40
/3
80
 n
m
 ra
tio
[%
]
Fu
ra
-2
 3
40
/3
80
 n
m
 ra
tio
[%
]
 
 
Fig. 3.14 5-HT induces Ca2+ release from intracellular stores followed by extracellular 
Ca2+ influx. 
Ratiometric [Ca2+]i recordings. A) 5-HT (10-5 M) induces a fast rise in [Ca2+]i with a 
subsequent short decline and then a phase of elevated [Ca2+]i levels. In AM stimulated with 
ATP (10-4 M), the Ca2+ response is weaker when compared to 5-HT. (B) Dependency of the 
5-HT-induced calcium increase on extracellular calcium. Cells exposed to 5-HT (10-5 M) in 
Ca2+-containing buffer show sustained increase in [Ca2+]i whereas cells stimulated in buffer 
without Ca2+ and supplemented with EGTA (3 x 10-6) exhibit only a transient rise in [Ca2+]i. 
Number of cells which reacted, and total number of measured cells are given in brackets. 
Differences in Fura-2 ratio immediately before application of agonist and after 6 or 20 s were 
tested for significance. *** indicates P≤0.001. 
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Fig. 3.15 5-HT has only a small effect on [Ca2+]i in NR8383 rat AM cells. 
Ratiometric [Ca2+]i recordings. NR8383 cells were stimulated with 5-HT (10-5 M) and ATP 
(10-4 M). Hepes buffer was used as a vehicle control. Depicted are recordings of [Ca2+]i in 191 
cells. 
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Fig. 3.16 Nicotine dampens agonist-induced increase in [Ca2+]i.  
Ratiometric [Ca2+]i recordings. Mouse BAL cells were stimulated with 5-HT (10-5 M) (A) or 
ATP (10-4 M) (B) in the presence or absence of nicotine (10-4 M). Number of cells which 
reacted, and total number of measured cells are given in brackets. Differences in Fura-2 ratio 
immediately before application of agonist and after time indicated by arrows were tested for 
significance. *** indicates P≤0.001. ** P≤0.01. 
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3.4.3 The 5-HT2C receptor is required for 5-HT-induced rise in [Ca2+]i 
To test whether the 5-HT-induced increase in [Ca2+]i is mediated by the 5-HT2C receptor, AM 
were incubated with the selective 5-HT2C blocker RS102221 (10-9 M) 2 min prior to 
stimulation with 5-HT. This markedly inhibited the 5-HT rise in [Ca2+]i without interfering 
with the ATP effect (Fig. 3.17A). 
Accordingly, the 5-HT effect was absent in 5-HT2C-receptor deficient animals. In the wild-
type AM, 5-HT induced a rapid rise in [Ca2+]i, whereas it had no effect on this parameter in 
the 5-HT2C receptor-deficient cells. Alveolar macrophages from both mouse strains were 
normally reactive to ATP, which served as a positive control (Fig. 3.17B).  
 
3.4.4 5-HT modulates chemokine and cytokine production  
Cytokine and chemokine production in AM was screened with a dot-blot based assay 
(“Mouse Cytokine Array”). In AM stimulated with 5-HT (10-5 M) for 24 h, there was an 
increase in signal intensity over unstimulated control for CCL2, and to a lesser degree for 
CCL5, TNFα, and CXCL1 proteins (Fig. 3.18). 
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Fig. 3.17 5-HT2C receptors are required for 5-HT-induced [Ca2+]i rise.  
Recordings of [Ca2+]i in AM. (A) Cells were incubated with the 5-HT2C receptor antagonist 
RS-102221 (10-9 M) 2 min prior to stimulation with 5-HT (10-5 M). Response to the 5-HT 
stimulus is blocked in treated cells, but the reaction to ATP is not blunted by the drug. (B) 
Cells harvested from 5-HT2C receptor deficient animals (5-HT2C-KO) and from littermate 
controls (5-HT2C-WT) were stimulated with 5-HT (10-5 M) and ATP (10-4 M). In wild-type 
cells, 5-HT induces [Ca2+]i rise which was absent in KO cells. All cells were reactive to ATP, 
serving as a positive control. Number of cells which reacted, and total number of measured 
cells are given in brackets. Differences in Fura-2 ratio immediately before application of 
agonist and after time indicated by arrows were tested for significance. *** indicates p<0.001. 
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Fig. 3.18 CCL2, CCL5, TNFα, and CXCL1 expression is increased in AM upon 5-HT 
stimulation.  
Mouse cytokine dot blot array was used to detect changes in AM secretions which were 
treated with 10-5 M 5-HT for 24 h (n=2). Ctrl = control spots. 
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4 Discussion 
Alveolar macrophages hold a key position in initiating pulmonary inflammatory responses by 
secreting TNFα and several additional cytokines and chemokines. These events are tightly 
regulated at the level of transcription, translation and secretion. Immune cells sense and signal 
to their environment by means of soluble mediators secreted by activated cells. In recent 
years, mediators that are primarily associated with neurotransmission have been recognized as 
potent modulators of immune cells. This thesis was focused on investigating acute cellular 
effects of nicotine and 5-HT upon AM. 
 
4.1 Modulation of alveolar macrophages by nAChR signaling 
We demonstrated acute receptor-dependent, modulatory effects of nicotine on AM. The 
nAChR involved in this process differ from subtypes reported previously to be involved in 
“cholinergic anti-inflammatory pathways” outside the lung. Although the effects of nicotine 
are receptor mediated, these receptors do not form a classical ion channel known from 
neuronal cells. Importantly, we were not able to detect the mRNA coding for α7 nAChR in 
both mouse and rat AM although this subunit was easily detectable in sensory neurons and in 
whole lung and brain homogenate. Immunofluorescence with two commercially available 
antibodies to nAChR α7 and immunoblotting with the monoclonal antibody mAb 306 on rat 
AM supported this finding. This is consistent with reported data on the lack of the expression 
of α7 nAChR in the murine AM cell line MH-S [61] and our previous work on expression of 
nAChR in freshly isolated murine AM [62] from FVB mice. In contrast, α7 nAChR are 
essential for systemic cholinergic anti-inflammation since the beneficial effects of nicotine in 
endotoxemia are abrogated in α7 subunit gene-deficient mice [64]. Accordingly, two potent 
α7 nAChR agonists, GTS-21 and PNU-282987 [98, 99], inhibit LPS-induced TNFα release 
and reduce acid-induced acute lung injury, respectively, in the mouse lung [68, 100]. Their 
potency on the most prevalent nAChR subunits identified in our present study on AM, i.e. α9 
and α10 nAChR that generally share many pharmacological properties with α7 nAChR [101], 
yet has not been determined. Without doubt, however, α7 nAChR is expressed in the lung as 
demonstrated by RT-PCR in this and previous studies [102, 103]. Functional data show 
increases in acid-induced excess lung water and vascular permeability in α7 nAChR deficient 
mice [68]. Nicotinic receptors located on endothelial cells may account for this effect [104]. 
However, since all α7 nAChR antibodies tested so far produce immunohistochemical labeling 
also in organs taken from α7 nAChR deficient mice [60, 105], immunohistochemistry alone 
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cannot decipher the cell-type specific α7-subunit distribution in the lung, and this issue 
remains to be solved. 
Instead of α7 we observed expression of nAChR subunits α9, α10, β1, and β2, and to a 
variable extent α2, α3, α5, in rat AM. Mouse AM expressed α9, α10, β2, and β4 nAChR 
subunits. In rat AM samples, we were able to amplify mRNA coding for α9 subunit only with 
SuperScriptII and not with iScript as reverse transcriptase system. This may be due to 
different priming strategies (oligo(dT) and blend of oligo(dT) + random hexamer primers, 
respectively) or to reduced RNAse H activity in SuperScriptII enzyme, which enables more 
efficient cDNA synthesis [106]. To form classical, ion-conducting nAChR, α subunits 
combine as heteropentamers with β subunits or build α heteropentamers of α9α10 and 
homopentamers of α7 and α9 (for a review, see [107]). The subunits detected in rat AM in the 
present study would allow combining the following nAChR pentamers: α3β2, α3α5β2, α9α10, 
and α9 as homopentamer. Since there is a constant expression of subunits α9 and α10 in AM, 
this combination as homo- or heteropentamer seems to be most likely, if pentamer formation 
occurs at all. 
These subunits have been best characterized in the inner ear, where they form Ca2+-permeable 
ion channels involved in efferent modulation of hair cell function [108, 109]. Interestingly, 
Ca2+ recordings in AM did not reveal changes in [Ca2+]i in response to nicotine. This notion 
was supported by whole-cell patch clamp recordings of AM done by Gitte Jositsch from Prof. 
Dr. W. Clauss laboratory, which did not show any transmembrane currents in response to 
ACh. This data are included in our manuscript on the receptor-mediated nicotinic effect on 
AM [110]. Similarly, a subpopulation of human T-lymphocytes expresses α9 and α10 nAChR 
subunits but fails to show transmembrane currents triggered by ACh [111], and nicotine does 
not cause alteration of [Ca2+]i in the rat AM cell line NR8383 [112] and in rat intravascular 
mononuclear leukocytes obtained from isogenic kidney transplants [55]. Thus, α9α10 nAChR 
subunits apparently do not form classical ionotropic receptors in cells of the immune system. 
Still, α9α10 nAChR subunits confer intracellular effects as our data demonstrate an acute α-
bungarotoxin sensitive modulatory effect of nicotine upon ATP-induced calcium release from 
intracellular stores. Similarly, we recently identified a methyllycaconitine sensitive 
modulatory effect of nicotine upon ATP-induced rise in [Ca2+]i in rat mononuclear leukocytes 
obtained by vascular perfusion of isogenic kidney transplants [55]. In line with this 
observation, α9 subunit containing nAChR in outer hair cells of the inner ear do not 
exclusively assemble into ionotropic receptors, but form metabotropic receptors as well. Here, 
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ACh also reduces ATP-induced rise in [Ca2+]i at a concentration that alone is insufficient to 
impact [Ca2+]i, and again this effect is α-bungarotoxin sensitive [113]. 
Atypical, non-ionotropic effects have also been reported for the nAChR α7 subunit. In T cells, 
this subunit fails to form a ligand-gated Ca2+ channel but interacts with CD3ζ to modulate 
TCR/CD3 function [54]. Notably, α7 subunits in this complex exhibit a different 
agonist/antagonists profile than neuronal ionotropic α7 nAChR. Methyllycaconitine and α-
bungarotoxin, both potent inhibitors of ionotropic α7 nAChR, indeed are strong agonists at T 
cells expressing nAChR α7 subunits [54]. Correspondingly, epibatidine, a highly potent 
agonist at ionotropic nAChR, failed to mimic the nicotine effect in our present experiments on 
rat AM.  
In contrast to the well-characterized channel properties of nAChR, the mechanisms of atypical 
nAChR signaling are currently only poorly understood. Membrane bound nAChR subunits 
have been demonstrated to interact with and to modulate signaling by β-arrestin [56], 
phosphatidyl-inositol-3-kinase [57], CD3ζ [54], and purinergic P2X-receptors [58, 59]. The 
latter are involved in ATP-induced increase in [Ca2+]i by extracellular influx in human AM, 
since initial Ca2+ transients are reduced by 40% in Ca2+-free medium [114]. In our present 
study of rat AM, however, the ATP-induced initial increase in [Ca2+]i and the modulatory 
effect of nicotine persisted in Ca2+-free solution, demonstrating interference of atypical 
nAChR with P2Y-receptor mediated Ca2+-release from intracellular stores. In support, we 
observed expression of P2Y purinergic receptors on AM, among them P2Y2 that mediates 
Ca2+-release from the ER in mouse macrophages [23]. Nicotinic receptors, whose mRNA was 
found in mouse AM, are also likely to mediate nicotine-induced decrease in response to ATP 
and 5-HT. Further studies are required to test if this nicotine effect is also receptor-dependent.  
Extracellular ATP is well recognized as a “danger” or “host tissue damage” signal and is 
mostly regarded to promote inflammation [115, 116]. In human AM, it couples to [Ca2+]i 
increases and stimulates IL-1β and IL-6 release albeit suppressing TNFα production [114]. In 
the rat AM cell line NR8383, ATP induces P2Y2- and Ca2+-dependent increase in CCL2 
synthesis and release [45]. As described in detail in chapter 4.2, the CCL2-CCR2 axis is a 
crucial regulator of inflammatory cell influx into the murine lung [5, 117]. Hence, the 
presently observed nicotinic attenuation of ATP-induced rise in [Ca2+]i can be considered as 
an anti-inflammatory mechanism triggered by atypical nAChR. 
In summary, AM are equipped with modulatory nAChR with properties distinct from 
ionotropic nAChR mediating synaptic transmission in the nervous system. Their stimulation 
with nicotine dampens ATP and 5-HT-induced Ca2+-release from intracellular stores in both 
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rat and mouse AM. Thus, the present study identifies the first acute receptor-mediated but 
atypical nicotinic effect on AM with anti-inflammatory potential. 
 
4.2 Serotonin modulates alveolar macrophage function via the 5-HT2C receptor. 
The current thesis provides the first evidence for functional expression of 5-HT2C receptors on 
mouse AM. In freshly isolated AM, 5-HT rapidly stimulates a rise in [Ca2+]i and leads to the 
increased production of CCL2, CCL5, TNFα.  
While many studies have investigated effects of 5-HT on cytokine production in various 
immune cells, little is know about the action of 5-HT upon AM. Acute effects of 5-HT on AM 
have not been investigated so far. Previous studies pointed to the importance of 5-HT2 
receptors in the development of bleomycin-induced pulmonary fibrosis in mice [118] and 
monocrotaline-induced pulmonary hypertension in rats [119]. The first evidence of 5-HT2C 
receptor expression on AM derived from a microarray study [120].  
In freshly isolated AM, RT-PCR revealed constitutive expression of 5-HT2C receptor mRNA 
while the two other 5-HT2 receptors were found in lower amounts. In contrast to previous 
report by Bubbar et al. [97], the polyclonal antibody sc-15081 directed against the 5-HT2C 
receptor failed to produce specific labeling, as evidenced from experiments with wild-type 
and 5-HT2C receptor-deficient mouse lung tissue sections. This finding may be explained by 
use of different batches of polyclonal antibody, which may differ in specificity.  
The presence and function of 5-HT2C receptors in AM were verified by [Ca2+]i measurements 
utilizing the Fura-2 assay. Stimulation with 5-HT resulted in a rapid increase in [Ca2+]i, 
characterized by a fast initial rise in [Ca2+]i and a subsequent phase of elevated Ca2+ levels, 
which was dependent on extracellular Ca2+. The initial 5-HT-induced increase was reduced in 
AM bathed in buffer lacking Ca2+. This might be caused by release of Ca2+ into the buffer, 
which may cause partial depletion of the intracellular Ca2+ stores. Indeed, mouse AM which 
were transferred to Ca2+-free buffer show a reduction in 340/380 nm Fura-2 ratio values when 
compared to cells kept in Hepes buffer with Ca2+. It is interesting that rat AM seem to be 
more resistant to decreased extracellular Ca2+ concentration, since in these cells we could not 
detect any differences in ATP-mediated [Ca2+]i rise in buffers with or without Ca2+. Therefore, 
it is likely that the initial rise in response to 5-HT relies on Ca2+ being mobilized from 
intracellular stores. The nature of the subsequent transmembrane influx of Ca2+ was not fully 
investigated, but it is likely that it occurs through mechanisms not related to ionotropic 5-HT 
receptors. Experiments with the selective 5-HT2C antagonist, RS102221 [121], showed that 
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this receptor is most likely responsible for the 5-HT-induced [Ca2+]i increase. To confirm this 
finding, as well as to prove the existence of 5-HT2C receptor on protein level, we used AM 
isolated from 5-HT2C receptor-deficient animals. These cells do not respond to 5-HT but react 
to other G-protein coupled receptor agonist, i.e. ATP. Thus, it is very likely that the 
deficiency in Ca2+ response to 5-HT is solely due to lack of its receptor and not to defects in 
signal transduction downstream of the receptor. 
As it has been shown in the section 1.5, changes in [Ca2+]i in macrophages have been 
associated with multiple functions. To investigate physiological responses of AM upon 5-HT 
stimulation we measured secretions of AM by a dot-blot based assay. Indeed, changes in 
production of inflammatory mediators were observed. Mainly CCL2, but also CCL5, TNFα, 
and CXCL1 production were increased by 5-HT stimulation. A limitation of the assay is its 
low dynamic range, therefore increase in expression of CCL2 upon 5-HT treatment was 
confirmed with ELISA (data shown in [122]). 
TNFα can be considered as the prototype of a large family of structurally related cytokines, 
which play a central role in the regulation of immune response [123]. The in vivo 
neutralization experiments with anti-TNFα antibodies demonstrated that the host defense 
against pathogens is severely impaired in the absence of TNFα [123, 124]. TNFα activates 
macrophages and neutrophils, stimulates the respiratory burst, and induces the production of 
leukocyte and vascular adhesion molecules, leading to enhanced transmigration into 
inflammatory sites [124]. In a murine model of Klebsiella spp pneumonia, in vivo 
neutralization of TNFα resulted in a 50% decrease in neutrophil influx to the lung with 
concomitant increase in number of bacteria recovered from lung and plasma, leading to 
increase in mortality (from 20% to 80%) [124]. However, excessive TNFα production is 
deleterious to the host. The presented data show that stimulation with 5-HT (10-5 M) increased 
production of TNFα in freshly isolated AM. Interestingly, in the rat NR8383 AM cell line as 
well as in human AM, 5-HT (10-10 M) decreased spontaneous as well as LPS-induced TNFα 
release [91]. This may suggest that 5-HT differentially modulates cellular responses in broad 
range of concentrations by acting on different 5-HT receptors. In support of that notion, 
experiments on NR8383 cells show a very small increase in [Ca2+]i upon 5-HT (10-5 M) 
stimulation, which in mouse AM was 5-HT2C receptor-dependent. 
CCL2 (also called MCP-1) is a major chemokine which drives monocyte recruitment to the 
lung under inflammatory conditions [5] in bacterial [6] and viral [7] models of lung 
inflammation. CCL2 is also involved in other inflammatory disorders of the lung, including 
allergic airway disease, acute respiratory distress syndrome and idiopathic pulmonary fibrosis 
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[125]. It has been shown that CCL2 production in the rat NR8383 AM cell line can be 
increased by ATP, and the release from induced cells can be attenuated after chelating 
intracellular Ca2+ with BAPTA [45]. Since CCL2 is stored in cytosolic granules [126], it is 
possible that 5-HT promotes CCL2 release via exocytosis which is a Ca2+-dependent process 
[43]. In addition, our results indicate that CCL2 mRNA expression starts early on after 4 h of 
stimulation with 5-HT [122]. 
CCL5 (also known as RANTES) is a chemokine which plays an active role in recruiting 
helper T cells, monocytes and eosinophils into inflammatory sites [127, 128]. In the lung 
however, CCL2 plays the predominant role in recruiting monocytes, as evidenced in the 
setting of viral inflammation [7]. Helper T cells play an important role in coordinating 
immune reaction, e.g. Th1 cells secrete interferon-γ which augments macrophage killing 
efficacy against ingested pathogens [129]. 
Neutrophil chemotaxis in enhanced by CXCL1 (also known as KC), which is produced only 
by activated cells, e.g. LPS-stimulated endothelial cells [130], peritoneal [131] and alveolar 
macrophages [132]. Interestingly, CXCL1-overexpressing mice show large neutrophil 
infiltrates with no signs of deleterious neutrophil activation [133]. Transgenic mice, with 
enhanced CXCL1 expression in the lung that are challenged with Klebsiella pneumoniae 
exhibit increased neutrophil number, improved bacterial clearance and survival [134]. The 
present study shows that 5-HT enhances CXCL1 expression in mouse AM in vitro. Enhanced 
infiltration of non-activated neutrophils may be beneficial for lung homeostasis, e.g. in 
bacterial infections. More experiments are required to clarify the effects of 5-HT on cytokine 
and chemokine balance in the lung in vivo.  
 
Serotonin levels are elevated in inflamed tissues [75]. Platelets release 5-HT in response to 
many stimuli, e.g. vascular wall injury, LPS [77] and following allergen challenge [78]. 
Platelets have been linked to many inflammatory disorders including acute lung injury [135], 
asthma, cystic fibrosis, atherosclerosis and sepsis [136]. It is likely that AM are reached by 
and react to 5-HT under local inflammatory conditions. It can be suggested that increased 
release of TNFα, CCL2, and CXCL1 by AM upon 5-HT stimulation may play a role in 
maintaining lung microenvironment, e.g. by promoting crosstalk between AM and AEC, 
stimulating AM in an autocrine or paracrine fashion. Moreover, cytokines and chemokines 
induced by 5-HT in AM may communicate information about local inflammatory conditions 
to circulating monocytes, neutrophils and helper T lymphocytes, which are crucial 
components of the immune response. 
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4.3 Conclusions 
The present study identified acute cellular effects of nicotine and 5-HT upon AM. While 5-
HT rapidly induced rise in [Ca2+]i, nicotine did not alter the level of [Ca2+]i in AM. This 
corroborates previous reports that nAChR subunits do not form classical ionotropic receptors 
in the cells of the immune system. In the presence of nicotine, they dampen Ca2+-release from 
intracellular stores induced by stimulation with 5-HT or ATP. Since rise in [Ca2+]i in AM is 
involved in pro-inflammatory signaling, the present study identifies the first acute receptor-
mediated but atypical nicotinic effect on AM with anti-inflammatory potential. The receptor 
subtypes involved and intracellular signaling pathways, as identified so far, differ from 
that known from the nervous system and from systemic cholinergic anti-inflammation. 
Potentially, this allows for selective pharmacological intervention and therapeutic use. 
This study identifies 5-HT as a novel modulator of AM function. We provide the first 
evidence for an exclusive role of the 5-HT2C receptor in serotonergic AM activation, assessed 
by increase in [Ca2+]i and changes in cytokine/chemokine profiles upon 5-HT treatment. 
Activation of AM by 5-HT might play an important role in communicating pro-thrombotic 
events in the pulmonary vasculature to resident lung immune cells. These data warrant 
consideration during pharmacological modulation of 5-HT metabolism and might offer an 
opportunity for the modification of AM function in vivo. 
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5 Summary 
Alveolar macrophages (AM) hold a key position in initiating inflammatory responses in the 
lung by secreting TNFα and several additional cytokines and chemokines. Their activity is 
controlled by paracrine signals such as ATP which might either be actively release as a 
signaling molecule or liberated during cell death, thereby reflecting a danger signal. The 
present study was aimed to determine to which extend, and via which receptor, serotonin (5-
HT), an amine released from activated platelets, and nicotinic acetylcholine receptors 
(nAChR), a receptor class that has been identified in mediating anti-inflammatory effects, also 
participate in paracrine modulation of AM function. 
The expression of 5-HT type 2 receptors and the effects evoked by stimulation with 5-HT 
were investigated in mouse AM. Expression of the 5-HT receptors was analyzed by RT-PCR. 
Alveolar macrophages expressed receptor subtypes 5-HT2A, 5-HT2B and 5-HT2C, with the 
strongest and most consistent expression being noted for 5-HT2C receptors. In mouse AM, 5-
HT (10-5 M) induced a rise in intracellular calcium concentration ([Ca2+]i) that was initiated 
by release of Ca2+ from intracellular stores and depended on extracellular Ca2+ in a sustained 
phase. This 5-HT-induced increase in [Ca2+]i was neither observed in AM treated with the 5-
HT2C receptor-selective inhibitor RS102221 nor in AM derived from 5-HT2C receptor-
deficient mice. Alveolar macrophages stimulated with 5-HT (10-5 M) showed increased 
production of CCL2, CCL5 and TNFα as determined by a dot-blot assay. These data 
demonstrate the presence of functional 5-HT2C receptors on AM and suggest a role of 5-HT as 
novel modulator of AM function. Importantly, these effects are exclusively driven by the 5-
HT2C receptor, thereby providing the potential for selective intervention. 
In addition, the nAChR inventory of freshly isolated rat and mouse AM was determined and 
the cellular events evoked by stimulation with nicotine were investigated. Positive RT-PCR 
results in rat AM were obtained for nAChR subunits α3, α5, α9, α10, β1, and β2, with most 
stable expression of subunits α9, α10, β1, and β2. Mouse AM expressed nAChR subunits α9, 
α10, β2 and β4. Notably, mRNA coding for subunit α7, which is proposed to convey the 
nicotinic anti-inflammatory response of macrophages from other sources than the lung, was 
not detected. RT-PCR data were supported by immunohistochemistry on rat AM isolated by 
lavage, as well as in lung tissue sections and by Western blotting. Measurements of [Ca2+]i in 
rat and mouse AM did not reveal any changes in response to nicotine. However, nicotine (10-4 
M), given 2 min prior to ATP and 5-HT, significantly reduced the agonist-induced rise in 
[Ca2+]i. This nicotinic effect was further studied in rat AM, where it was blocked by α-
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bungarotoxin and did not depend on the presence of extracellular calcium. These data 
demonstrate that AM are equipped with modulatory nAChR with properties distinct from 
ionotropic nAChR mediating synaptic transmission in the nervous system. Their stimulation 
with nicotine dampens ATP-induced Ca2+-release from intracellular stores. Thus, the present 
study identifies the first acute receptor-mediated nicotinic effect on AM with anti-
inflammatory potential.  
Taken together, 5-HT, an amine released from activated platelets, and nAChR, a receptor 
class that has been identified in mediating anti-inflammatory effects, participate in paracrine 
modulation of AM function. Serotonergic stimulation of 5-HT2C receptors activates AM, 
whereas nAChR confer an inhibitory influence upon both serotonergic and purinergic 
activation via pathways differing from those known from the nervous system. These data 
warrant consideration during pharmacological modulation of cholinergic transmission and 5-
HT metabolism and might offer an opportunity to modify AM function in vivo. 
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6 Zusammenfassung 
Alveolarmakrophagen (AM) nehmen eine Schlüsselstellung in Entzündungsreaktionen in der 
Lunge ein, die sie durch die Sekretion von TNFα sowie weiteren Cytokinen und Chemokinen 
einleiten. Ihre Aktivität steht unter der Kontrolle parakriner Signale, beispielsweise ATP, 
welches entweder aktiv sezerniert wird, oder bei Zelltod freigesetzt wird und dann ein 
Gefahrensignal darstellt. Die vorliegende Studie hatte das Ziel festzustellen, in welchem 
Ausmaß und über welchen Rezeptor Serotonin (5-HT) - ein biogenes Amin, das von 
aktivierten Thrombozyten freigesetzt wird - und nikotinische Azetylcholinrezeptoren 
(nAChR) - eine Rezeptorklasse, die anti-inflammatorische Mechanismen vermitteln kann – 
ebenfalls an der parakrinen Modulation von AM beteiligt sind. 
Die Expression von 5-HT-Rezeptoren des Typs 2 und die Auswirkungen einer serotonergen 
Stimulation wurden an AM der Maus untersucht. RT-PCR zeigte die Expression der 
Rezeptorsubtypen 5-HT2A, 5-HT2B sowie 5-HT2C, wobei der 5-HT2C-Subtyp bei weitem am 
stärksten exprimiert war. In AM der Maus bewirkte 5-HT (10-5 M) einen Anstieg der 
intrazellulären Kalziumkonzentration ([Ca2+]i), der durch eine Freisetzung aus intrazellulären 
Speichern initiiert wurde und in seiner Aufrechterhaltung von extrazellulärem Kalzium 
abhängig war. Dieser 5-HT-bedingte [Ca2+]i-Anstieg war nach Gabe des 5-HT2C-
Rezeptorantagonisten RS102221 und in AM von 5-HT2C-Rezeptor-gendefizienten Mäuse 
nicht zu beobachten. Ein Dot-Blot-Assay zeigte eine vermehrte Produktion von CCL2, CCL5 
und TNFα durch AM nach Stimulation mit 5-HT (10-5 M). Diese Daten zeigen das 
Vorkommen funktioneller 5-HT2C-Rezeptoren auf AM und implizieren, dass 5-HT ein neu 
identifizierter Modulator der AM-Funktion ist. Da der serotonerge Effekt ausschließlich über 
den 5-HT2C-Rezeptor vermittelt wird, ergibt sich das Potenzial einer selektiven Intervention. 
Weiterführend wurden das Inventar an nAChR von frisch isolierten AM der Maus und Ratte 
und die durch Nikotin hervorgerufenen zellulären Effekte untersucht. In der Ratte ergaben 
sich positive RT-PCR-Befunde für die nAChR-Untereinheiten α3, α5, α9, α10, β1 und β2, 
mit konstanter Expression der Untereinheiten α9, α10, β1 und β2. Maus-AM zeigten 
Expression der nAChR-Untereinheiten α9, α10, β1 und β4. Es ist hervorzuheben, dass 
mRNA der α7-Untereinheit, welche für die anti-inflammatorische Wirkung von Nikotin auf 
Makrophagen anderer Organe als der Lunge verantwortlich gemacht wird, nicht nachweisbar 
war. Die RT-PCR-Befunde wurden durch Immunhistochemie an lavagierten Ratten-AM und 
Gewebeschnitten der Lunge sowie durch Western blot gestützt. Weder Maus- noch Ratten-
AM reagierten auf Nikotin mit einer direkten Änderung der [Ca2+]i, aber sowohl der 5-HT- als 
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auch der ATP-induzierte [Ca2+]i-Anstieg wurde durch eine vorherige (2 min) Gabe von 
Nikotin (10-4 M) signifikant abgeschwächt. Dieser Nikotineffekt wurde in der Ratte weiter 
analysiert. Er war unabhängig von extrazellulärem Kalzium und ließ sich durch α-
Bungarotoxin hemmen. Diese Befunde zeigen, dass AM mit modulierend wirkenden nAChR 
ausgestattet sind, deren Eigenschaften sich von den ionotropen nAChR des Nervensystems 
unterschieden, die dort die cholinerge synaptische Übertragung vermitteln. In AM dämpft ihre 
Stimulation die ATP-induzierte Freisetzung von Kalzium aus intrazellulären Speichern. Die 
vorliegende Arbeit identifiziert somit den ersten akuten rezeptorvermittelten nikotinischen 
Effekt auf AM. 
Zusammenfassend sind sowohl 5-HT - ein biogenes Amin, das von aktivierten Thrombozyten 
freigesetzt wird – als auch nAChR - eine Rezeptorklasse, die anti-inflammatorische 
Mechanismen vermitteln kann – an der parakrinen Modulation von AM beteiligt. Serotonin 
stimuliert AM über 5-HT2C-Rezeptoren, während nAChR über Signalwege, die sich von 
denen aus dem Nervensystem bekannten unterscheiden, einen inhibitorischen Einfluss auf 
serotonerge und purinerge AM-Aktivierung ausübt. Diese Daten sollten bei der 
pharmakologischen Modulation cholinerger Transmission und des 5-HT-Metabolismus 
berücksichtigt werden und könnten zugleich eine Möglichkeit der Modulation der AM-
Aktivität in vivo bieten. 
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